{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:35:28Z","timestamp":1790224528588,"version":"4.1.0"},"reference-count":337,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The physiological state of the tumor microenvironment (TME) plays a central role in cancer development due to multiple universal features that transcend heterogeneity and niche specifications, like promoting cancer progression and metastasis. As a result of their preponderant involvement in tumor growth and maintenance through several microsystemic alterations, including hypoxia, oxidative stress, and acidosis, TMEs make for ideal targets in both diagnostic and therapeutic ventures. Correspondingly, methodologies to target TMEs have been investigated this past decade as stratagems of significant potential in the genre of focused cancer treatment. Within targeted oncotherapy, nanomedical derivates\u2014nanocarriers (NCs) especially\u2014have emerged to present notable prospects in enhancing targeting specificity. Yet, one major issue in the application of NCs in microenvironmental directed therapy is that TMEs are too broad a spectrum of targeting possibilities for these carriers to be effectively employed. However, cancer stem cells (CSCs) might portend a solution to the above conundrum: aside from being quite heavily invested in tumorigenesis and therapeutic resistance, CSCs also show self-renewal and fluid clonogenic properties that often define specific TME niches. Further scrutiny of the relationship between CSCs and TMEs also points towards mechanisms that underly tumoral characteristics of metastasis, malignancy, and even resistance. This review summarizes recent advances in NC-enabled targeting of CSCs for more holistic strikes against TMEs and discusses both the current challenges that hinder the clinical application of these strategies as well as the avenues that can further CSC-targeting initiatives.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>\n                <jats:p>Central role of CSCs in regulation of cellular components within the TME<\/jats:p>","DOI":"10.1007\/s12015-022-10426-9","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T15:07:47Z","timestamp":1658761667000},"page":"2209-2233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1596-9984","authenticated-orcid":false,"given":"Aadya","family":"Nayak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9321-2923","authenticated-orcid":false,"given":"Neerada Meenakshi","family":"Warrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6330-7355","authenticated-orcid":false,"given":"Praveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"10426_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc2618","volume":"9","author":"JA Joyce","year":"2009","unstructured":"Joyce, J. A., & Pollard, J. W. (2009). Microenvironmental regulation of metastasis. Nature Reviews Cancer, 9, 239\u2013252. https:\/\/doi.org\/10.1038\/nrc2618","journal-title":"Nature Reviews Cancer"},{"key":"10426_CR2","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill, F. R., Capasso, M., & Hagemann, T. (2012). The tumor microenvironment at a glance. Journal of Cell Science, 125, 5591\u20135596. https:\/\/doi.org\/10.1242\/jcs.116392","journal-title":"Journal of Cell Science"},{"key":"10426_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/medicina56010015","volume":"56","author":"B Arneth","year":"2020","unstructured":"Arneth, B. (2020). Tumor microenvironment. Medicina, 56, 15. https:\/\/doi.org\/10.3390\/medicina56010015","journal-title":"Medicina"},{"key":"10426_CR4","doi-asserted-by":"publisher","unstructured":"Henke, E., Nandigama, R., Erg\u00fcn, S. (2020). Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy. Frontiers in Molecular Biosciences, 6. https:\/\/doi.org\/10.3389\/fmolb.2019.00160","DOI":"10.3389\/fmolb.2019.00160"},{"key":"10426_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fcell.2019.00086","volume":"7","author":"S Nallanthighal","year":"2019","unstructured":"Nallanthighal, S., Heiserman, J. P., & Cheon, D. J. (2019). The Role of the Extracellular Matrix in Cancer Stemness. Frontiers in Cell and Developmental Biology, 7, 86. https:\/\/doi.org\/10.3389\/fcell.2019.00086","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10426_CR6","doi-asserted-by":"crossref","unstructured":"Islam, F., Gopalan, V., Lam, A. K. Y. (2018). Cancer stem cells: Role in tumor progression and treatment resistance. In: Oncogenomics: From Basic Research to Precision Medicine. Elsevier, pp 77\u201387","DOI":"10.1016\/B978-0-12-811785-9.00006-5"},{"key":"10426_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/cancers12040879","volume":"12","author":"A Osman","year":"2020","unstructured":"Osman, A., Afify, S. M., Hassan, G., et al. (2020). Revisiting cancer stem cells as the origin of cancer-associated cells in the tumor microenvironment: A hypothetical view from the potential of iPSCs. Cancers (Basel), 12, 879. https:\/\/doi.org\/10.3390\/cancers12040879","journal-title":"Cancers (Basel)"},{"key":"10426_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang, M., Zhao, J., Zhang, L., et al. (2017). Role of tumor microenvironment in tumorigenesis. Journal of Cancer, 8, 761\u2013773. https:\/\/doi.org\/10.7150\/jca.17648","journal-title":"Journal of Cancer"},{"key":"10426_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. (2016). The biology and function of fibroblasts in cancer. Nature Reviews Cancer, 16, 582\u2013598. https:\/\/doi.org\/10.1038\/nrc.2016.73","journal-title":"Nature Reviews Cancer"},{"key":"10426_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.trecan.2020.12.014","volume":"7","author":"LP Ferguson","year":"2021","unstructured":"Ferguson, L. P., Diaz, E., & Reya, T. (2021). The Role of the Microenvironment and Immune System in Regulating Stem Cell Fate in Cancer. Trends in Cancer, 7, 624\u2013634. https:\/\/doi.org\/10.1016\/j.trecan.2020.12.014","journal-title":"Trends in Cancer"},{"key":"10426_CR11","doi-asserted-by":"publisher","unstructured":"Phi, L.T.H., Sari, I.N., Yang, Y.G., et al. (2018). Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells International, 2018. https:\/\/doi.org\/10.1155\/2018\/5416923","DOI":"10.1155\/2018\/5416923"},{"key":"10426_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2021.01.020","volume":"506","author":"Q Shen","year":"2021","unstructured":"Shen, Q., Hill, T., Cai, X., et al. (2021). Physical confinement during cancer cell migration triggers therapeutic resistance and cancer stem cell-like behavior. Cancer Letters, 506, 142\u2013151. https:\/\/doi.org\/10.1016\/j.canlet.2021.01.020","journal-title":"Cancer Letters"},{"key":"10426_CR13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","volume":"12","author":"I Khan","year":"2019","unstructured":"Khan, I., Saeed, K., & Khan, I. (2019). Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry, 12, 908\u2013931. https:\/\/doi.org\/10.1016\/j.arabjc.2017.05.011","journal-title":"Arabian Journal of Chemistry"},{"key":"10426_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1477-3155-10-31","volume":"10","author":"M Fakruddin","year":"2012","unstructured":"Fakruddin, M., Hossain, Z., & Afroz, H. (2012). Prospects and applications of nanobiotechnology: A medical perspective. J Nanobiotechnology, 10, 31. https:\/\/doi.org\/10.1186\/1477-3155-10-31","journal-title":"J Nanobiotechnology"},{"key":"10426_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s13346-020-00743-2","volume":"10","author":"JP Martins","year":"2020","unstructured":"Martins, J. P., das Neves J, de la Fuente M, et al. (2020). The solid progress of nanomedicine. Drug Delivery and Translational Research, 10, 726\u2013729. https:\/\/doi.org\/10.1007\/s13346-020-00743-2","journal-title":"Drug Delivery and Translational Research"},{"key":"10426_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s13346-019-00679-2","volume":"10","author":"L Jena","year":"2020","unstructured":"Jena, L., McErlean, E., & McCarthy, H. (2020). Delivery across the blood-brain barrier: Nanomedicine for glioblastoma multiforme. Drug Delivery and Translational Research, 10, 304\u2013318. https:\/\/doi.org\/10.1007\/s13346-019-00679-2","journal-title":"Drug Delivery and Translational Research"},{"key":"10426_CR17","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.15252\/emmm.201505413","volume":"7","author":"M Valenza","year":"2015","unstructured":"Valenza, M., Chen, J. Y., Di Paolo, E., et al. (2015). Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in H untington\u2019s disease mice. EMBO Molecular Medicine, 7, 1547\u20131564. https:\/\/doi.org\/10.15252\/emmm.201505413","journal-title":"EMBO Molecular Medicine"},{"key":"10426_CR18","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari, S., Atluri, V., Kaushik, A., et al. (2019). Alzheimer\u2019s disease: Pathogenesis, diagnostics, and therapeutics. International Journal of Nanomedicine, 14, 5541\u20135554. https:\/\/doi.org\/10.2147\/IJN.S200490","journal-title":"International Journal of Nanomedicine"},{"key":"10426_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1080\/1061186X.2018.1533556","volume":"27","author":"S Mizrahy","year":"2019","unstructured":"Mizrahy, S., Gutkin, A., Decuzzi, P., & Peer, D. (2019). Targeting central nervous system pathologies with nanomedicines. Journal of Drug Targeting, 27, 542\u2013554. https:\/\/doi.org\/10.1080\/1061186X.2018.1533556","journal-title":"Journal of Drug Targeting"},{"key":"10426_CR20","doi-asserted-by":"publisher","unstructured":"(2019) The two directions of cancer nanomedicine. Nature Nanotechnology, 14:1083. https:\/\/doi.org\/10.1038\/s41565-019-0597-5","DOI":"10.1038\/s41565-019-0597-5"},{"key":"10426_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jconrel.2020.07.007","volume":"326","author":"M Germain","year":"2020","unstructured":"Germain, M., Caputo, F., Metcalfe, S., et al. (2020). Delivering the power of nanomedicine to patients today. Journal of Controlled Release, 326, 164\u2013171. https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.007","journal-title":"Journal of Controlled Release"},{"key":"10426_CR22","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm, S., Tavares, A. J., Dai, Q., et al. (2016). Analysis of nanoparticle delivery to tumours. Nature Reviews Materials, 1, 16014. https:\/\/doi.org\/10.1038\/natrevmats.2016.14","journal-title":"Nature Reviews Materials"},{"key":"10426_CR23","doi-asserted-by":"crossref","unstructured":"Madkour, L.H. (2019). Nanoparticle and polymeric nanoparticle-based targeted drug delivery systems. In: Nucleic Acids as Gene Anticancer Drug Delivery Therapy. Elsevier, pp 191\u2013240","DOI":"10.1016\/B978-0-12-819777-6.00013-5"},{"key":"10426_CR24","doi-asserted-by":"publisher","unstructured":"Ertas, Y.N., Dorcheh, K.A., Akbari, A., Jabbari, E. (2021). Nanoparticles for targeted drug delivery to cancer stem cells: A review of recent advances. Nanomaterials 11. https:\/\/doi.org\/10.3390\/nano11071755","DOI":"10.3390\/nano11071755"},{"key":"10426_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.engreg.2020.06.001","volume":"1","author":"T Malachowski","year":"2020","unstructured":"Malachowski, T., & Hassel, A. (2020). Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery. Eng Regen, 1, 35\u201350. https:\/\/doi.org\/10.1016\/j.engreg.2020.06.001","journal-title":"Eng Regen"},{"key":"10426_CR26","doi-asserted-by":"publisher","unstructured":"Valdivia-Olivares, R.Y., Rodriguez-Fernandez, M., \u00c1lvarez-Figueroa, M.J., et al. (2021). The importance of nanocarrier design and composition for an efficient nanoparticle-mediated transdermal vaccination. Vaccines 9. https:\/\/doi.org\/10.3390\/vaccines9121420","DOI":"10.3390\/vaccines9121420"},{"key":"10426_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40580-019-0193-2","volume":"6","author":"PN Navya","year":"2019","unstructured":"Navya, P. N., Kaphle, A., Srinivas, S. P., et al. (2019). Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano Convergence, 6, 23. https:\/\/doi.org\/10.1186\/s40580-019-0193-2","journal-title":"Nano Convergence"},{"key":"10426_CR28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.molonc.2011.10.005","volume":"5","author":"E Blanco","year":"2011","unstructured":"Blanco, E., Hsiao, A., Ruiz-Esparza, G. U., et al. (2011). Molecular-targeted nanotherapies in cancer: Enabling treatment specificity. Molecular Oncology, 5, 492\u2013503. https:\/\/doi.org\/10.1016\/j.molonc.2011.10.005","journal-title":"Molecular Oncology"},{"key":"10426_CR29","doi-asserted-by":"publisher","first-page":"S448","DOI":"10.1080\/21691401.2018.1499661","volume":"46","author":"FT Hsu","year":"2018","unstructured":"Hsu, F. T., Wei, Z. H., Hsuan, Y. C. Y., et al. (2018). MRI tracking of polyethylene glycol-coated superparamagnetic iron oxide-labelled placenta-derived mesenchymal stem cells toward glioblastoma stem-like cells in a mouse model. Artif Cells, Nanomedicine Biotechnol, 46, S448\u2013S459. https:\/\/doi.org\/10.1080\/21691401.2018.1499661","journal-title":"Artif Cells, Nanomedicine Biotechnol"},{"key":"10426_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1021\/acs.bioconjchem.6b00522","volume":"28","author":"N Guldris","year":"2017","unstructured":"Guldris, N., Argibay, B., Gallo, J., et al. (2017). Magnetite Nanoparticles for Stem Cell Labeling with High Efficiency and Long-Term in Vivo Tracking. Bioconjugate Chemistry, 28, 362\u2013370. https:\/\/doi.org\/10.1021\/acs.bioconjchem.6b00522","journal-title":"Bioconjugate Chemistry"},{"key":"10426_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11033-018-4460-9","volume":"46","author":"RL Azevedo-Pereira","year":"2019","unstructured":"Azevedo-Pereira, R. L., Rangel, B., Tovar-Moll, F., et al. (2019). Superparamagnetic iron oxide nanoparticles as a tool to track mouse neural stem cells in vivo. Molecular Biology Reports, 46, 191\u2013198. https:\/\/doi.org\/10.1007\/s11033-018-4460-9","journal-title":"Molecular Biology Reports"},{"key":"10426_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep01150","volume":"3","author":"K Li","year":"2013","unstructured":"Li, K., Qin, W., Ding, D., et al. (2013). Photostable fluorescent organic dots with aggregation-induced emission (AIE dots) for noninvasive long-term cell tracing. Science and Reports, 3, 1\u201310. https:\/\/doi.org\/10.1038\/srep01150","journal-title":"Science and Reports"},{"key":"10426_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10426_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-019-02189-8","volume":"18","author":"B Cacho-D\u00edaz","year":"2020","unstructured":"Cacho-D\u00edaz, B., Garc\u00eda-Botello, D. R., Wegman-Ostrosky, T., et al. (2020). Tumor microenvironment differences between primary tumor and brain metastases. Journal of Translational Medicine, 18, 1. https:\/\/doi.org\/10.1186\/s12967-019-02189-8","journal-title":"Journal of Translational Medicine"},{"key":"10426_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12935-019-1027-3","volume":"19","author":"R Zhang","year":"2019","unstructured":"Zhang, R., Liu, Q., Li, T., et al. (2019). Role of the complement system in the tumor microenvironment. Cancer Cell International, 19, 300. https:\/\/doi.org\/10.1186\/s12935-019-1027-3","journal-title":"Cancer Cell International"},{"key":"10426_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017). Emerging Biological Principles of Metastasis. Cell, 168, 670\u2013691. https:\/\/doi.org\/10.1016\/j.cell.2016.11.037","journal-title":"Cell"},{"key":"10426_CR37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.canlet.2015.12.033","volume":"380","author":"M Pietil\u00e4","year":"2016","unstructured":"Pietil\u00e4, M., Ivaska, J., & Mani, S. A. (2016). Whom to blame for metastasis, the epithelial\u2013mesenchymal transition or the tumor microenvironment? Cancer Letters, 380, 359\u2013368. https:\/\/doi.org\/10.1016\/j.canlet.2015.12.033","journal-title":"Cancer Letters"},{"key":"10426_CR38","doi-asserted-by":"publisher","unstructured":"Catal\u00e1n, V., G\u00f3mez-Ambrosi, J., Rodr\u00edguez, A., Fr\u00fchbeck, G. (2013). Adipose tissue immunity and cancer. Frontiers in Physiology 4 OCT. https:\/\/doi.org\/10.3389\/fphys.2013.00275","DOI":"10.3389\/fphys.2013.00275"},{"key":"10426_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/cphy.c170008","volume":"8","author":"AJ Cozzo","year":"2018","unstructured":"Cozzo, A. J., Fuller, A. M., & Makowski, L. (2018). Contribution of adipose tissue to development of cancer. Comprehensive Physiology, 8, 237\u2013282. https:\/\/doi.org\/10.1002\/cphy.c170008","journal-title":"Comprehensive Physiology"},{"key":"10426_CR40","doi-asserted-by":"publisher","unstructured":"LeBleu, V.S., Kalluri, R. (2018). A peek into cancer-associated fibroblasts: Origins, functions and translational impact. Disease Models & Mechanisms, 11. https:\/\/doi.org\/10.1242\/dmm.029447","DOI":"10.1242\/dmm.029447"},{"key":"10426_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fcell.2019.00060","volume":"7","author":"T Liu","year":"2019","unstructured":"Liu, T., Zhou, L., Li, D., et al. (2019). Cancer-associated fibroblasts build and secure the tumor microenvironment. Frontiers in Cell and Developmental Biology, 7, 60. https:\/\/doi.org\/10.3389\/fcell.2019.00060","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10426_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fimmu.2018.00527","volume":"9","author":"A Albini","year":"2018","unstructured":"Albini, A., Bruno, A., Noonan, D. M., & Mortara, L. (2018). Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy. Frontiers in Immunology, 9, 527. https:\/\/doi.org\/10.3389\/fimmu.2018.00527","journal-title":"Frontiers in Immunology"},{"key":"10426_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan, D., & Coussens, L. M. (2012). Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment. Cancer Cell, 21, 309\u2013322. https:\/\/doi.org\/10.1016\/j.ccr.2012.02.022","journal-title":"Cancer Cell"},{"key":"10426_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188608","volume":"1876","author":"CC Picoli","year":"2021","unstructured":"Picoli, C. C., Gon\u00e7alves, B. \u00d4. P., Santos, G. S. P., et al. (2021). Pericytes cross-talks within the tumor microenvironment. Biochimica et Biophysica Acta - Reviews on Cancer, 1876, 188608. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188608","journal-title":"Biochimica et Biophysica Acta - Reviews on Cancer"},{"key":"10426_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti, D., Tamma, R., & Annese, T. (2020). Epithelial-Mesenchymal Transition in Cancer: A Historical Overview. Translational Oncology, 13, 100773. https:\/\/doi.org\/10.1016\/j.tranon.2020.100773","journal-title":"Translational Oncology"},{"key":"10426_CR46","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1093\/annonc\/mdy399","volume":"29","author":"B Szekely","year":"2018","unstructured":"Szekely, B., Bossuyt, V., Li, X., et al. (2018). Immunological differences between primary and metastatic breast cancer. Annals of Oncology, 29, 2232\u20132239. https:\/\/doi.org\/10.1093\/annonc\/mdy399","journal-title":"Annals of Oncology"},{"key":"10426_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-07960-z","volume":"21","author":"A Zeppellini","year":"2021","unstructured":"Zeppellini, A., Galimberti, S., Leone, B. E., et al. (2021). Comparison of tumor microenvironment in primary and paired metastatic ER+\/HER2- breast cancers: Results of a pilot study. BMC Cancer, 21, 1\u201310. https:\/\/doi.org\/10.1186\/s12885-021-07960-z","journal-title":"BMC Cancer"},{"key":"10426_CR48","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3390\/cells8070714","volume":"8","author":"S Heeke","year":"2019","unstructured":"Heeke, S., Mograbi, B., Alix-Panabi\u00e8res, C., & Hofman, P. (2019). Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment. Cells, 8, 714. https:\/\/doi.org\/10.3390\/cells8070714","journal-title":"Cells"},{"key":"10426_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/diagnostics8030059","volume":"8","author":"K Leone","year":"2018","unstructured":"Leone, K., Poggiana, C., & Zamarchi, R. (2018). The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy. Diagnostics, 8, 59. https:\/\/doi.org\/10.3390\/diagnostics8030059","journal-title":"Diagnostics"},{"key":"10426_CR50","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1002\/CAM4.2327","volume":"8","author":"J Wang","year":"2019","unstructured":"Wang, J., Li, D., Cang, H., & Guo, B. (2019). Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment. Cancer Medicine, 8, 4709\u20134721. https:\/\/doi.org\/10.1002\/CAM4.2327","journal-title":"Cancer Medicine"},{"key":"10426_CR51","doi-asserted-by":"publisher","unstructured":"Rahat, M.A., Shakya, J. (2016). Parallel Aspects of the Microenvironment in Cancer and Autoimmune Disease. Mediators Inflamm, 2016. https:\/\/doi.org\/10.1155\/2016\/4375120","DOI":"10.1155\/2016\/4375120"},{"key":"10426_CR52","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1158\/2159-8290.CD-17-0284","volume":"8","author":"OMT Pearce","year":"2018","unstructured":"Pearce, O. M. T., Delaine-Smith, R. M., Maniati, E., et al. (2018). Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discovery, 8, 304\u2013319. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0284","journal-title":"Cancer Discovery"},{"key":"10426_CR53","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3389\/fimmu.2020.00940","volume":"11","author":"A Labani-Motlagh","year":"2020","unstructured":"Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020). The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses. Frontiers in Immunology, 11, 940. https:\/\/doi.org\/10.3389\/fimmu.2020.00940","journal-title":"Frontiers in Immunology"},{"key":"10426_CR54","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1038\/s41598-020-60255-4","volume":"10","author":"GE Idos","year":"2020","unstructured":"Idos, G. E., Kwok, J., Bonthala, N., et al. (2020). The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis. Science and Reports, 10, 3360. https:\/\/doi.org\/10.1038\/s41598-020-60255-4","journal-title":"Science and Reports"},{"key":"10426_CR55","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F., & Joyce, J. A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nature Medicine, 19, 1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394","journal-title":"Nature Medicine"},{"key":"10426_CR56","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1053\/j.seminoncol.2015.01.001","volume":"42","author":"JA Ajani","year":"2015","unstructured":"Ajani, J. A., Song, S., Hochster, H. S., & Steinberg, I. B. (2015). Cancer stem cells: The promise and the potential. Seminars in Oncology, 42, S3\u2013S17. https:\/\/doi.org\/10.1053\/j.seminoncol.2015.01.001","journal-title":"Seminars in Oncology"},{"key":"10426_CR57","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1002\/jcp.27740","volume":"234","author":"M Najafi","year":"2019","unstructured":"Najafi, M., Farhood, B., & Mortezaee, K. (2019). Cancer stem cells (CSCs) in cancer progression and therapy. Journal of Cellular Physiology, 234, 8381\u20138395. https:\/\/doi.org\/10.1002\/jcp.27740","journal-title":"Journal of Cellular Physiology"},{"key":"10426_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang, L., Shi, P., Zhao, G., et al. (2020). Targeting cancer stem cell pathways for cancer therapy. Signal Transduction and Targeted Therapy, 5, 1\u201335. https:\/\/doi.org\/10.1038\/s41392-020-0110-5","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10426_CR59","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/cancers11030345","volume":"11","author":"SM Afify","year":"2019","unstructured":"Afify, S. M., & Seno, M. (2019). Conversion of stem cells to cancer stem cells: Undercurrent of cancer initiation. Cancers (Basel), 11, 345. https:\/\/doi.org\/10.3390\/cancers11030345","journal-title":"Cancers (Basel)"},{"key":"10426_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/S41048-018-0062-2","volume":"4","author":"P Zhu","year":"2018","unstructured":"Zhu, P., & Fan, Z. (2018). Cancer stem cells and tumorigenesis. Biophys Reports, 4, 178. https:\/\/doi.org\/10.1007\/S41048-018-0062-2","journal-title":"Biophys Reports"},{"issue":"16","key":"10426_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12943-017-0601-3","volume":"161","author":"C Gasch","year":"2017","unstructured":"Gasch, C., Ffrench, B., & O\u2019Leary, J. J. (2017). Gallagher MF (2017) Catching moving targets: Cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention. Molecular Cancer, 161(16), 1\u201315. https:\/\/doi.org\/10.1186\/S12943-017-0601-3","journal-title":"Molecular Cancer"},{"key":"10426_CR62","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/J.STEM.2014.02.006","volume":"14","author":"A Kreso","year":"2014","unstructured":"Kreso, A., & Dick, J. E. (2014). Evolution of the Cancer Stem Cell Model. Cell Stem Cell, 14, 275\u2013291. https:\/\/doi.org\/10.1016\/J.STEM.2014.02.006","journal-title":"Cell Stem Cell"},{"key":"10426_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FONC.2021.678333","volume":"11","author":"X Zheng","year":"2021","unstructured":"Zheng, X., Yu, C., & Xu, M. (2021). Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy. Frontiers in Oncology, 11, 1. https:\/\/doi.org\/10.3389\/FONC.2021.678333","journal-title":"Frontiers in Oncology"},{"key":"10426_CR64","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1073\/PNAS.1220200110\/SUPPL_FILE\/SD01.XLS","volume":"110","author":"T Hikichi","year":"2013","unstructured":"Hikichi, T., Matoba, R., Ikeda, T., et al. (2013). Transcription factors interfering with dedifferentiation induce cell type-specific transcriptional profiles. Proc Natl Acad Sci U S A, 110, 6412\u20136417. https:\/\/doi.org\/10.1073\/PNAS.1220200110\/SUPPL_FILE\/SD01.XLS","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10426_CR65","doi-asserted-by":"publisher","unstructured":"Poli, V., Fagnocchi, L., Zippo, A. (2018). Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics. Stem Cells International, 2018. https:\/\/doi.org\/10.1155\/2018\/4598195","DOI":"10.1155\/2018\/4598195"},{"key":"10426_CR66","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/IJC.33398","volume":"148","author":"R French","year":"2021","unstructured":"French, R., & Pauklin, S. (2021). Epigenetic regulation of cancer stem cell formation and maintenance. International Journal of Cancer, 148, 2884. https:\/\/doi.org\/10.1002\/IJC.33398","journal-title":"International Journal of Cancer"},{"key":"10426_CR67","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3389\/fimmu.2020.01280","volume":"11","author":"L Walcher","year":"2020","unstructured":"Walcher, L., Kistenmacher, A. K., Suo, H., et al. (2020). Cancer Stem Cells\u2014Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Frontiers in Immunology, 11, 1280. https:\/\/doi.org\/10.3389\/fimmu.2020.01280","journal-title":"Frontiers in Immunology"},{"key":"10426_CR68","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4252\/WJSC.V13.I7.934","volume":"13","author":"V Kaushik","year":"2021","unstructured":"Kaushik, V., Kulkarni, Y., Felix, K., et al. (2021). Alternative models of cancer stem cells: The stemness phenotype model, 10 years later. World J Stem Cells, 13, 934. https:\/\/doi.org\/10.4252\/WJSC.V13.I7.934","journal-title":"World J Stem Cells"},{"key":"10426_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-07144-5","volume":"7","author":"N Nair","year":"2017","unstructured":"Nair, N., Calle, A. S., Zahra, M. H., et al. (2017). A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment. Science and Reports, 7, 1\u201313. https:\/\/doi.org\/10.1038\/s41598-017-07144-5","journal-title":"Science and Reports"},{"key":"10426_CR70","doi-asserted-by":"publisher","unstructured":"Sadozai, H., Acharjee, A., Eppenberger-Castori, S., et al. (2021). Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer. Frontiers in Immunology, 12. https:\/\/doi.org\/10.3389\/fimmu.2021.643529","DOI":"10.3389\/fimmu.2021.643529"},{"key":"10426_CR71","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/hep.31792","volume":"73","author":"M Song","year":"2021","unstructured":"Song, M., He, J., Pan, Q. Z., et al. (2021). Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression. Hepatology, 73, 1717\u20131735. https:\/\/doi.org\/10.1002\/hep.31792","journal-title":"Hepatology"},{"key":"10426_CR72","doi-asserted-by":"publisher","unstructured":"Wei, L., Ye, H., Li, G., et al. (2018). Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1\/SATB-1 pathway in pancreatic cancer. Cell Death & Disease, 9. https:\/\/doi.org\/10.1038\/s41419-018-1104-x","DOI":"10.1038\/s41419-018-1104-x"},{"key":"10426_CR73","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12015-019-09942-y","volume":"16","author":"PK Das","year":"2020","unstructured":"Das, P. K., Pillai, S., Rakib, M. A., et al. (2020). Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance. Stem Cell Rev Reports, 16, 397\u2013412. https:\/\/doi.org\/10.1007\/s12015-019-09942-y","journal-title":"Stem Cell Rev Reports"},{"key":"10426_CR74","doi-asserted-by":"publisher","unstructured":"Cazet, A.S., Hui, M.N., Elsworth, B.L., et al. (2018). Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer. Nature Communications, 9. https:\/\/doi.org\/10.1038\/s41467-018-05220-6","DOI":"10.1038\/s41467-018-05220-6"},{"key":"10426_CR75","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10549-021-06136-4","volume":"187","author":"C Strell","year":"2021","unstructured":"Strell, C., Stenmark Tullberg, A., Jetne Edelmann, R., et al. (2021). Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: Results from the randomized SweBCG91RT trial. Breast Cancer Research and Treatment, 187, 45\u201355. https:\/\/doi.org\/10.1007\/s10549-021-06136-4","journal-title":"Breast Cancer Research and Treatment"},{"key":"10426_CR76","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/imm.12866","volume":"153","author":"AS Codd","year":"2018","unstructured":"Codd, A. S., Kanaseki, T., Torigo, T., & Tabi, Z. (2018). Cancer stem cells as targets for immunotherapy. Immunology, 153, 304\u2013314. https:\/\/doi.org\/10.1111\/imm.12866","journal-title":"Immunology"},{"key":"10426_CR77","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3389\/fonc.2020.00764","volume":"10","author":"Y Cho","year":"2020","unstructured":"Cho, Y., & Kim, Y. K. (2020). Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance. Frontiers in Oncology, 10, 764. https:\/\/doi.org\/10.3389\/fonc.2020.00764","journal-title":"Frontiers in Oncology"},{"issue":"6","key":"10426_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00430-1","volume":"61","author":"HM Zhou","year":"2021","unstructured":"Zhou, H. M., Zhang, J. G., & Zhang, X. (2021). Li Q (2021) Targeting cancer stem cells for reversing therapy resistance: Mechanism, signaling, and prospective agents. Signal Transduction and Targeted Therapy, 61(6), 1\u201317. https:\/\/doi.org\/10.1038\/s41392-020-00430-1","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10426_CR79","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-09-2846","volume":"16","author":"AA Merchant","year":"2010","unstructured":"Merchant, A. A., & Matsui, W. (2010). Targeting Hedgehog - A cancer stem cell pathway. Clinical Cancer Research, 16, 3130\u20133140. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-2846","journal-title":"Clinical Cancer Research"},{"key":"10426_CR80","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/emmm.200900042","volume":"1","author":"A Gulino","year":"2009","unstructured":"Gulino, A., Ferretti, E., & De Smaele, E. (2009). Hedgehog signalling in colon cancer and stem cells. EMBO Molecular Medicine, 1, 300\u2013302. https:\/\/doi.org\/10.1002\/emmm.200900042","journal-title":"EMBO Molecular Medicine"},{"key":"10426_CR81","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00204-014-1433-1","volume":"89","author":"Y Jia","year":"2015","unstructured":"Jia, Y., Wang, Y., & Xie, J. (2015). The Hedgehog pathway: Role in cell differentiation, polarity and proliferation. Archives of Toxicology, 89, 179\u2013191. https:\/\/doi.org\/10.1007\/s00204-014-1433-1","journal-title":"Archives of Toxicology"},{"key":"10426_CR82","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.2147\/OTT.S139639","volume":"10","author":"C Wu","year":"2017","unstructured":"Wu, C., Zhu, X., Liu, W., et al. (2017). Hedgehog signaling pathway in colorectal cancer: Function, mechanism, and therapy. Oncotargets and Therapy, 10, 3249\u20133259. https:\/\/doi.org\/10.2147\/OTT.S139639","journal-title":"Oncotargets and Therapy"},{"key":"10426_CR83","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1615\/CritRevOncog.2016016976","volume":"21","author":"AR Safa","year":"2016","unstructured":"Safa, A. R. (2016). Resistance to cell death and its modulation in cancer stem cells. Critical Reviews in Oncogenesis, 21, 203\u2013219. https:\/\/doi.org\/10.1615\/CritRevOncog.2016016976","journal-title":"Critical Reviews in Oncogenesis"},{"key":"10426_CR84","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3390\/cells9102204","volume":"9","author":"M BeLow","year":"2020","unstructured":"BeLow, M., & Osipo, C. (2020). Notch Signaling in Breast Cancer: A Role in Drug Resistance. Cells, 9, 2204. https:\/\/doi.org\/10.3390\/cells9102204","journal-title":"Cells"},{"key":"10426_CR85","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/cas.12978","volume":"107","author":"X Lin","year":"2016","unstructured":"Lin, X., Sun, B., Zhu, D., et al. (2016). Notch4+ cancer stem-like cells promote the metastatic and invasive ability of melanoma. Cancer Science, 107, 1079\u20131091. https:\/\/doi.org\/10.1111\/cas.12978","journal-title":"Cancer Science"},{"key":"10426_CR86","doi-asserted-by":"crossref","unstructured":"Rajendran DT, Subramaniyan B, Ganeshan M (2018) Role of notch signaling in colorectal cancer. In: Role of Transcription Factors in Gastrointestinal Malignancies. pp 305\u2013312","DOI":"10.1007\/978-981-10-6728-0_21"},{"key":"10426_CR87","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.3390\/cells9081879","volume":"9","author":"CT Meisel","year":"2020","unstructured":"Meisel, C. T., Porcheri, C., & Mitsiadis, T. A. (2020). Cancer Stem Cells, Quo Vadis? The Notch Signaling Pathway in Tumor Initiation and Progression. Cells, 9, 1879. https:\/\/doi.org\/10.3390\/cells9081879","journal-title":"Cells"},{"key":"10426_CR88","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/cancers9050040","volume":"9","author":"B Nami","year":"2017","unstructured":"Nami, B., & Wang, Z. (2017). HER2 in breast cancer stemness: A negative feedback loop towards trastuzumab resistance. Cancers (Basel), 9, 40. https:\/\/doi.org\/10.3390\/cancers9050040","journal-title":"Cancers (Basel)"},{"key":"10426_CR89","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.critrevonc.2015.12.005","volume":"99","author":"Y Duchartre","year":"2016","unstructured":"Duchartre, Y., Kim, Y. M., & Kahn, M. (2016). The Wnt signaling pathway in cancer. Critical Reviews in Oncology Hematology, 99, 141\u2013149. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.12.005","journal-title":"Critical Reviews in Oncology Hematology"},{"key":"10426_CR90","doi-asserted-by":"publisher","unstructured":"Yan, Y., Liu, F., Han, L., et al. (2018). HIF-2\u03b1 promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways. Journal of Experimental & Clinical Cancer Research, 37. https:\/\/doi.org\/10.1186\/s13046-018-0925-x","DOI":"10.1186\/s13046-018-0925-x"},{"key":"10426_CR91","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s12282-016-0708-1","volume":"24","author":"T Nagata","year":"2017","unstructured":"Nagata, T., Shimada, Y., Sekine, S., et al. (2017). KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer. Breast Cancer, 24, 326\u2013335. https:\/\/doi.org\/10.1007\/s12282-016-0708-1","journal-title":"Breast Cancer"},{"key":"10426_CR92","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1002\/jcp.30063","volume":"236","author":"B Najafzadeh","year":"2021","unstructured":"Najafzadeh, B., Asadzadeh, Z., Motafakker Azad, R., et al. (2021). The oncogenic potential of NANOG: An important cancer induction mediator. Journal of Cellular Physiology, 236, 2443\u20132458. https:\/\/doi.org\/10.1002\/jcp.30063","journal-title":"Journal of Cellular Physiology"},{"key":"10426_CR93","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1158\/0008-5472.CAN-17-0366","volume":"77","author":"CD House","year":"2017","unstructured":"House, C. D., Jordan, E., Hernandez, L., et al. (2017). NFkB promotes ovarian tumorigenesis via classical pathways that support proliferative cancer cells and alternative pathways that support ALDH\u00fe cancer stem\u2013like cells. Cancer Research, 77, 6927\u20136940. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0366","journal-title":"Cancer Research"},{"key":"10426_CR94","doi-asserted-by":"publisher","first-page":"ii7","DOI":"10.1093\/noajnl\/vdab070.027","volume":"3","author":"M Volmar","year":"2021","unstructured":"Volmar, M., Cheng, J., Synowitz, M., et al. (2021). OMRT-1. Cannabidiol converts NFKB into a tumor-suppressor in glioblastoma with defined antioxidative properties. Neuro-Oncology Advances, 3, ii7\u2013ii7. https:\/\/doi.org\/10.1093\/noajnl\/vdab070.027","journal-title":"Neuro-Oncology Advances"},{"key":"10426_CR95","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3389\/FONC.2019.00965\/BIBTEX","volume":"9","author":"RC Gimple","year":"2019","unstructured":"Gimple, R. C., & Wang, X. (2019). RAS: Striking at the Core of the Oncogenic Circuitry. Frontiers in Oncology, 9, 965. https:\/\/doi.org\/10.3389\/FONC.2019.00965\/BIBTEX","journal-title":"Frontiers in Oncology"},{"key":"10426_CR96","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1042\/BST20200964","volume":"49","author":"R Chippalkatti","year":"2021","unstructured":"Chippalkatti, R., & Abankwa, D. (2021). Promotion of cancer cell stemness by Ras. Biochemical Society Transactions, 49, 467. https:\/\/doi.org\/10.1042\/BST20200964","journal-title":"Biochemical Society Transactions"},{"key":"10426_CR97","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1158\/0008-5472.CAN-11-3132","volume":"72","author":"DJ Mulholland","year":"2012","unstructured":"Mulholland, D. J., Kobayashi, N., Ruscetti, M., et al. (2012). Pten loss and RAS\/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem\/progenitor cells. Cancer Research, 72, 1878\u20131889. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3132","journal-title":"Cancer Research"},{"key":"10426_CR98","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.biotechadv.2011.08.001","volume":"30","author":"G Vitale","year":"2012","unstructured":"Vitale, G., Zappavigna, S., Marra, M., et al. (2012). The PPAR-\u03b3 agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-\u03b2 treated pancreatic cancer cells. Biotechnology Advances, 30, 169\u2013184. https:\/\/doi.org\/10.1016\/j.biotechadv.2011.08.001","journal-title":"Biotechnology Advances"},{"key":"10426_CR99","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1016\/J.BBADIS.2018.08.024","volume":"1864","author":"M Xu","year":"2018","unstructured":"Xu, M., Wang, S., Wang, Y., et al. (2018). Role of p38\u03b3 MAPK in Regulation of EMT and Cancer Stem Cells. Biochimica et Biophysica Acta, Molecular Basis of Disease, 1864, 3605. https:\/\/doi.org\/10.1016\/J.BBADIS.2018.08.024","journal-title":"Biochimica et Biophysica Acta, Molecular Basis of Disease"},{"key":"10426_CR100","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.7150\/IJBS.57871","volume":"17","author":"J Li","year":"2021","unstructured":"Li, J., Wang, J., Xie, D., et al. (2021). Characteristics of the PI3K\/AKT and MAPK\/ERK pathways involved in the maintenance of self-renewal in lung cancer stem-like cells. International Journal of Biological Sciences, 17, 1191. https:\/\/doi.org\/10.7150\/IJBS.57871","journal-title":"International Journal of Biological Sciences"},{"key":"10426_CR101","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.2147\/DDDT.S247730","volume":"14","author":"I Vel\u00e1zquez-Quesada","year":"2020","unstructured":"Vel\u00e1zquez-Quesada, I., Ruiz-Moreno, A. J., Casique-Aguirre, D., et al. (2020). Pranlukast antagonizes cd49f and reduces stemness in triple-negative breast cancer cells. Drug Design, Development and Therapy, 14, 1799\u20131811. https:\/\/doi.org\/10.2147\/DDDT.S247730","journal-title":"Drug Design, Development and Therapy"},{"key":"10426_CR102","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1042\/BST20190778","volume":"48","author":"RR Madsen","year":"2020","unstructured":"Madsen, R. R. (2020). PI3K in stemness regulation: From development to cancer. Biochemical Society Transactions, 48, 301\u2013315. https:\/\/doi.org\/10.1042\/BST20190778","journal-title":"Biochemical Society Transactions"},{"key":"10426_CR103","doi-asserted-by":"publisher","unstructured":"Liffers, K., Lamszus, K., Schulte, A. (2015). EGFR Amplification and Glioblastoma Stem-Like Cells. Stem Cells International, 2015. https:\/\/doi.org\/10.1155\/2015\/427518","DOI":"10.1155\/2015\/427518"},{"key":"10426_CR104","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.2147\/CMAR.S253500","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Han, Y., Xu, S., et al. (2020). Targeting EGFR Enriches Stem Cell-Like Properties in Salivary Adenoid Cystic Carcinoma by Activating the Notch1 Pathway<\/p>. Cancer Manag Res, 12, 6655\u20136663. https:\/\/doi.org\/10.2147\/CMAR.S253500","journal-title":"Cancer Manag Res"},{"issue":"12","key":"10426_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-04265-w","volume":"121","author":"Y Xu","year":"2022","unstructured":"Xu, Y., Afify, S. M., Du, J., et al. (2022). (2022) The efficacy of PI3K\u03b3 and EGFR inhibitors on the suppression of the characteristics of cancer stem cells. Sci Reports, 121(12), 1\u201311. https:\/\/doi.org\/10.1038\/s41598-021-04265-w","journal-title":"Sci Reports"},{"issue":"25","key":"10426_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12929-018-0426-4","volume":"251","author":"AZ Ayob","year":"2018","unstructured":"Ayob, A. Z. (2018). Ramasamy TS (2018) Cancer stem cells as key drivers of tumour progression. Journal of Biomedical Science, 251(25), 1\u201318. https:\/\/doi.org\/10.1186\/S12929-018-0426-4","journal-title":"Journal of Biomedical Science"},{"key":"10426_CR107","doi-asserted-by":"publisher","unstructured":"Aramini, B., Masciale, V., Grisendi, G., et al. (2022). Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers (Basel), 14. https:\/\/doi.org\/10.3390\/CANCERS14040976","DOI":"10.3390\/CANCERS14040976"},{"key":"10426_CR108","doi-asserted-by":"publisher","unstructured":"Kahn, B.M., Lucas, A., Alur, R.G., et al. (2021). The vascular landscape of human cancer. The Journal of Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI136655","DOI":"10.1172\/JCI136655"},{"key":"10426_CR109","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/S00018-019-03351-7\/FIGURES\/3","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano, R., Ramachandran, M., & Dimberg, A. (2020). Tumor angiogenesis: Causes, consequences, challenges and opportunities. Cellular and Molecular Life Sciences, 77, 1745\u20131770. https:\/\/doi.org\/10.1007\/S00018-019-03351-7\/FIGURES\/3","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10426_CR110","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/J.RETH.2021.02.006","volume":"17","author":"H Tsuchiya","year":"2021","unstructured":"Tsuchiya, H., & Shiota, G. (2021). Immune evasion by cancer stem cells. Regenerative Therapy, 17, 20\u201333. https:\/\/doi.org\/10.1016\/J.RETH.2021.02.006","journal-title":"Regenerative Therapy"},{"issue":"11","key":"10426_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2361-z","volume":"113","author":"J Chen","year":"2020","unstructured":"Chen, J., Chen, S., Zhuo, L., et al. (2020). (2020) Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p\/SOX2 axis in colorectal cancer. Cell Death & Disease, 113(11), 1\u201313. https:\/\/doi.org\/10.1038\/s41419-020-2361-z","journal-title":"Cell Death & Disease"},{"key":"10426_CR112","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/FCELL.2019.00353\/BIBTEX","volume":"7","author":"J Baruah","year":"2020","unstructured":"Baruah, J., & Wary, K. K. (2020). Exosomes in the Regulation of Vascular Endothelial Cell Regeneration. Front Cell Dev Biol, 7, 353. https:\/\/doi.org\/10.3389\/FCELL.2019.00353\/BIBTEX","journal-title":"Front Cell Dev Biol"},{"key":"10426_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12967-020-02426-5\/FIGURES\/5","volume":"18","author":"M Ahmadi","year":"2020","unstructured":"Ahmadi, M., & Rezaie, J. (2020). Tumor cells derived-exosomes as angiogenenic agents: Possible therapeutic implications. Journal of Translational Medicine, 18, 1\u201317. https:\/\/doi.org\/10.1186\/S12967-020-02426-5\/FIGURES\/5","journal-title":"Journal of Translational Medicine"},{"key":"10426_CR114","doi-asserted-by":"publisher","unstructured":"Mongiat, M., Andreuzzi, E., Tarticchio, G., Paulitti, A. (2016). Extracellular Matrix, a Hard Player in Angiogenesis. International Journal of Molecular Sciences, 17. https:\/\/doi.org\/10.3390\/IJMS17111822","DOI":"10.3390\/IJMS17111822"},{"key":"10426_CR115","doi-asserted-by":"publisher","unstructured":"Radomska-Le\u015bniewska, D. M., Bia\u0142oszewska, A., Kami\u0144ski, P. (2021). Angiogenic Properties of NK Cells in Cancer and Other Angiogenesis-Dependent Diseases. Cells ,10. https:\/\/doi.org\/10.3390\/CELLS10071621","DOI":"10.3390\/CELLS10071621"},{"issue":"5","key":"10426_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-0134-x","volume":"51","author":"J Fares","year":"2020","unstructured":"Fares, J., Fares, M. Y., Khachfe, H. H., et al. (2020). (2020) Molecular principles of metastasis: A hallmark of cancer revisited. Signal Transduction and Targeted Therapy, 51(5), 1\u201317. https:\/\/doi.org\/10.1038\/s41392-020-0134-x","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10426_CR117","doi-asserted-by":"publisher","first-page":"36137","DOI":"10.18632\/ONCOTARGET.16661","volume":"8","author":"X Sun","year":"2017","unstructured":"Sun, X., Ma, X., Wang, J., et al. (2017). Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21\/VEGF signal. Oncotarget, 8, 36137\u201336148. https:\/\/doi.org\/10.18632\/ONCOTARGET.16661","journal-title":"Oncotarget"},{"key":"10426_CR118","doi-asserted-by":"publisher","unstructured":"Treps, L., Perret, R., Edmond, S., et al. (2017). Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles. Journal of Extracellular Vesicles, 6. https:\/\/doi.org\/10.1080\/20013078.2017.1359479","DOI":"10.1080\/20013078.2017.1359479"},{"key":"10426_CR119","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3389\/FONC.2020.00413","volume":"10","author":"E Liz\u00e1rraga-Verdugo","year":"2020","unstructured":"Liz\u00e1rraga-Verdugo, E., Avenda\u00f1o-F\u00e9lix, M., Berm\u00fadez, M., et al. (2020). Cancer Stem Cells and Its Role in Angiogenesis and Vasculogenic Mimicry in Gastrointestinal Cancers. Frontiers in Oncology, 10, 413. https:\/\/doi.org\/10.3389\/FONC.2020.00413","journal-title":"Frontiers in Oncology"},{"key":"10426_CR120","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1182\/BLOOD-2018-01-769018","volume":"132","author":"AM Randi","year":"2018","unstructured":"Randi, A. M., Smith, K. E., & Castaman, G. (2018). von Willebrand factor regulation of blood vessel formation. Blood, 132, 132\u2013140. https:\/\/doi.org\/10.1182\/BLOOD-2018-01-769018","journal-title":"Blood"},{"key":"10426_CR121","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1111\/JTH.14976","volume":"18","author":"S Patmore","year":"2020","unstructured":"Patmore, S., Dhami, S. P. S., & O\u2019Sullivan, J. M. (2020). Von Willebrand factor and cancer; metastasis and coagulopathies. Journal of Thrombosis and Haemostasis, 18, 2444\u20132456. https:\/\/doi.org\/10.1111\/JTH.14976","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10426_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/J.TRANON.2021.101033","volume":"14","author":"CY Goh","year":"2021","unstructured":"Goh, C. Y., Patmore, S., Smolenski, A., et al. (2021). The role of von Willebrand factor in breast cancer metastasis. Transl Oncol, 14, 101033. https:\/\/doi.org\/10.1016\/J.TRANON.2021.101033","journal-title":"Transl Oncol"},{"key":"10426_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/OL.2022.13319","volume":"23","author":"X Li","year":"2022","unstructured":"Li, X., & Lu, Z. (2022). Role of von Willebrand factor in the angiogenesis of lung adenocarcinoma (Review). Oncology Letters, 23, 1\u20137. https:\/\/doi.org\/10.3892\/OL.2022.13319","journal-title":"Oncology Letters"},{"key":"10426_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/JEV2.12167","volume":"10","author":"T Wang","year":"2021","unstructured":"Wang, T., Wang, X., Wang, H., et al. (2021). High TSPAN8 expression in epithelial cancer cell-derived small extracellular vesicles promote confined diffusion and pronounced uptake. J Extracell Vesicles, 10, e12167. https:\/\/doi.org\/10.1002\/JEV2.12167","journal-title":"J Extracell Vesicles"},{"key":"10426_CR125","doi-asserted-by":"publisher","unstructured":"Mu, W., Provaznik, J., Hackert, T., Z\u00f6ller, M. (2020). Tspan8-Tumor Extracellular Vesicle-Induced Endothelial Cell and Fibroblast Remodeling Relies on the Target Cell-Selective Response. Cells, 9. https:\/\/doi.org\/10.3390\/CELLS9020319","DOI":"10.3390\/CELLS9020319"},{"issue":"10","key":"10426_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1431-6","volume":"103","author":"C Chen","year":"2019","unstructured":"Chen, C., Xu, Z. Q., Zong, Y. P., et al. (2019). CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT\/NF-\u03baB pathway in colorectal cancer. Cell Death & Disease, 103(10), 1\u201315. https:\/\/doi.org\/10.1038\/s41419-019-1431-6","journal-title":"Cell Death & Disease"},{"key":"10426_CR127","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/CAC2.12010","volume":"40","author":"W Zhang","year":"2020","unstructured":"Zhang, W., Wang, H., Sun, M., et al. (2020). CXCL5\/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Cancer Communications, 40, 69. https:\/\/doi.org\/10.1002\/CAC2.12010","journal-title":"Cancer Communications"},{"key":"10426_CR128","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3389\/FONC.2021.637023\/BIBTEX","volume":"11","author":"Y Nie","year":"2021","unstructured":"Nie, Y., Jiang, M. C., Liu, C., et al. (2021). CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates. Frontiers in Oncology, 11, 802. https:\/\/doi.org\/10.3389\/FONC.2021.637023\/BIBTEX","journal-title":"Frontiers in Oncology"},{"key":"10426_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/J.CYTO.2021.155471","volume":"141","author":"M Mac\u00edas","year":"2021","unstructured":"Mac\u00edas, M., Garc\u00eda-Cort\u00e9s, \u00c1., Torres, M., et al. (2021). Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients. Cytokine, 141, 155471. https:\/\/doi.org\/10.1016\/J.CYTO.2021.155471","journal-title":"Cytokine"},{"key":"10426_CR130","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/CANCERS11040529","volume":"11","author":"L Soumoy","year":"2019","unstructured":"Soumoy, L., Kindt, N., Ghanem, G., et al. (2019). Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma. Cancers, 11, 529. https:\/\/doi.org\/10.3390\/CANCERS11040529","journal-title":"Cancers"},{"key":"10426_CR131","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.3389\/FIMMU.2020.609948\/BIBTEX","volume":"11","author":"JT Noe","year":"2020","unstructured":"Noe, J. T., & Mitchell, R. A. (2020). MIF-Dependent Control of Tumor Immunity. Frontiers in Immunology, 11, 3078. https:\/\/doi.org\/10.3389\/FIMMU.2020.609948\/BIBTEX","journal-title":"Frontiers in Immunology"},{"issue":"12","key":"10426_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-03426-z","volume":"122","author":"L Klemke","year":"2021","unstructured":"Klemke, L., De Oliveira, T., Witt, D., et al. (2021). (2021) Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer. Cell Death & Disease, 122(12), 1\u201316. https:\/\/doi.org\/10.1038\/s41419-021-03426-z","journal-title":"Cell Death & Disease"},{"key":"10426_CR133","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1158\/1541-7786.MCR-21-0526\/674497\/AM\/UVEAL-MELANOMA-EXOSOMES-INDUCE-A-PRO-METASTATIC","volume":"20","author":"G Ambrosini","year":"2022","unstructured":"Ambrosini, G., Rai, A. J., Carvajal, R. D., & Schwartz, G. K. (2022). Uveal Melanoma Exosomes Induce a Prometastatic Microenvironment through Macrophage Migration Inhibitory Factor. Molecular Cancer Research, 20, 661\u2013669. https:\/\/doi.org\/10.1158\/1541-7786.MCR-21-0526\/674497\/AM\/UVEAL-MELANOMA-EXOSOMES-INDUCE-A-PRO-METASTATIC","journal-title":"Molecular Cancer Research"},{"key":"10426_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS21218412","volume":"21","author":"J Korbecki","year":"2020","unstructured":"Korbecki, J., Kojder, K., Simi\u0144ska, D., et al. (2020). CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4. International Journal of Molecular Sciences, 21, 1\u201329. https:\/\/doi.org\/10.3390\/IJMS21218412","journal-title":"International Journal of Molecular Sciences"},{"key":"10426_CR135","doi-asserted-by":"publisher","unstructured":"Bule, P., Aguiar, S. I., Aires-Da-silva, F., Dias, J. N. R. (2021). Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. International Journal of Molecular Sciences, 22. https:\/\/doi.org\/10.3390\/IJMS22189804","DOI":"10.3390\/IJMS22189804"},{"key":"10426_CR136","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/FENDO.2022.846310\/BIBTEX","volume":"13","author":"A Gilchrist","year":"2022","unstructured":"Gilchrist, A., & Echeverria, S. L. (2022). Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma. Front Endocrinol (Lausanne), 13, 283. https:\/\/doi.org\/10.3389\/FENDO.2022.846310\/BIBTEX","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10426_CR137","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/J.APSB.2021.01.001","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu, J., Ren, L., Li, S., et al. (2021). The biology, function, and applications of exosomes in cancer. Acta Pharm Sin B, 11, 2783. https:\/\/doi.org\/10.1016\/J.APSB.2021.01.001","journal-title":"Acta Pharm Sin B"},{"key":"10426_CR138","doi-asserted-by":"publisher","unstructured":"Ruehle, M. A., Eastburn, E. A., LaBelle, S. A., et al. (2020). Extracellular matrix compression temporally regulates microvascular angiogenesis. Science Advances, 6. https:\/\/doi.org\/10.1126\/SCIADV.ABB6351\/SUPPL_FILE\/ABB6351_SM.PDF","DOI":"10.1126\/SCIADV.ABB6351\/SUPPL_FILE\/ABB6351_SM.PDF"},{"key":"10426_CR139","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.3389\/FIMMU.2020.613114\/BIBTEX","volume":"11","author":"R Abou Khouzam","year":"2021","unstructured":"Abou Khouzam, R., Brodaczewska, K., Filipiak, A., et al. (2021). Tumor Hypoxia Regulates Immune Escape\/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies. Frontiers in Immunology, 11, 3479. https:\/\/doi.org\/10.3389\/FIMMU.2020.613114\/BIBTEX","journal-title":"Frontiers in Immunology"},{"key":"10426_CR140","doi-asserted-by":"publisher","first-page":"14115","DOI":"10.1021\/jacs.1c03875","volume":"143","author":"JH Kim","year":"2021","unstructured":"Kim, J. H., Verwilst, P., Won, M., et al. (2021). A Small Molecule Strategy for Targeting Cancer Stem Cells in Hypoxic Microenvironments and Preventing Tumorigenesis. Journal of the American Chemical Society, 143, 14115\u201314124. https:\/\/doi.org\/10.1021\/jacs.1c03875","journal-title":"Journal of the American Chemical Society"},{"key":"10426_CR141","doi-asserted-by":"publisher","unstructured":"Bhuria, V., Xing, J., Scholta, T., et al. (2019). Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinoma. Experimental Cell Research, 385. https:\/\/doi.org\/10.1016\/J.YEXCR.2019.111671","DOI":"10.1016\/J.YEXCR.2019.111671"},{"key":"10426_CR142","doi-asserted-by":"publisher","first-page":"13435","DOI":"10.1096\/FJ.201900722R","volume":"33","author":"CHV Nascimento-Filho","year":"2019","unstructured":"Nascimento-Filho, C. H. V., Webber, L. P., Borgato, G. B., et al. (2019). Hypoxic niches are endowed with a protumorigenic mechanism that supersedes the protective function of PTEN. The FASEB Journal, 33, 13435\u201313449. https:\/\/doi.org\/10.1096\/FJ.201900722R","journal-title":"The FASEB Journal"},{"key":"10426_CR143","doi-asserted-by":"publisher","unstructured":"Zhang, Q., Han, Z., Zhu, Y., et al. (2021). Role of hypoxia inducible factor-1 in cancer stem cells. Molecular Medicine Reports, 23. https:\/\/doi.org\/10.3892\/MMR.2020.11655","DOI":"10.3892\/MMR.2020.11655"},{"key":"10426_CR144","doi-asserted-by":"publisher","unstructured":"Huang, Y., Chen, Z., Lu, T., et al. (2021). HIF-1\u03b1 switches the functionality of TGF-\u03b2 signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research, 40. https:\/\/doi.org\/10.1186\/S13046-021-02188-Y","DOI":"10.1186\/S13046-021-02188-Y"},{"key":"10426_CR145","doi-asserted-by":"publisher","unstructured":"Tam, S.Y., Wu, V. W. C., Law, H. K. W. (2020). Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1\u03b1 and Beyond. Frontiers in Oncology, 10. https:\/\/doi.org\/10.3389\/FONC.2020.00486","DOI":"10.3389\/FONC.2020.00486"},{"key":"10426_CR146","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4048\/JBC.2018.21.E42","volume":"21","author":"J Peng","year":"2018","unstructured":"Peng, J., Wang, X., Ran, L., et al. (2018). Hypoxia-Inducible Factor 1\u03b1 Regulates the Transforming Growth Factor \u03b21\/SMAD Family Member 3 Pathway to Promote Breast Cancer Progression. Journal of Breast Cancer, 21, 259. https:\/\/doi.org\/10.4048\/JBC.2018.21.E42","journal-title":"Journal of Breast Cancer"},{"key":"10426_CR147","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/CARCIN\/BGT027","volume":"34","author":"Q Zhang","year":"2013","unstructured":"Zhang, Q., Bai, X., Chen, W., et al. (2013). Wnt\/\u03b2-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1\u03b1 signaling. Carcinogenesis, 34, 962\u2013973. https:\/\/doi.org\/10.1093\/CARCIN\/BGT027","journal-title":"Carcinogenesis"},{"key":"10426_CR148","doi-asserted-by":"publisher","unstructured":"Lin, Y. Te, Wu, K. J. (2020). Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-\u03b2 signaling. Journal of Biomedical Science, 27. https:\/\/doi.org\/10.1186\/S12929-020-00632-3","DOI":"10.1186\/S12929-020-00632-3"},{"key":"10426_CR149","doi-asserted-by":"publisher","unstructured":"Fu, Y., Bao, Q., Liu, Z., et al. (2021). Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration. Frontiers in Cell and Developmental Biology, 9. https:\/\/doi.org\/10.3389\/FCELL.2021.633607","DOI":"10.3389\/FCELL.2021.633607"},{"key":"10426_CR150","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/1566524018666181109121849","volume":"18","author":"A Pezzuto","year":"2018","unstructured":"Pezzuto, A., & Carico, E. (2018). Role of HIF-1 in Cancer Progression: Novel Insights. A Review. Curr Mol Med, 18, 343\u2013351. https:\/\/doi.org\/10.2174\/1566524018666181109121849","journal-title":"A Review. Curr Mol Med"},{"key":"10426_CR151","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/HEP.32009","volume":"74","author":"H Sun","year":"2021","unstructured":"Sun, H., Meng, Q., Shi, C., et al. (2021). Hypoxia-Inducible Exosomes Facilitate Liver-Tropic Premetastatic Niche in Colorectal Cancer. Hepatology, 74, 2633\u20132651. https:\/\/doi.org\/10.1002\/HEP.32009","journal-title":"Hepatology"},{"key":"10426_CR152","doi-asserted-by":"publisher","unstructured":"Vander Linden, C., Corbet, C. (2019). Therapeutic Targeting of Cancer Stem Cells: Integrating and Exploiting the Acidic Niche. Frontiers in Oncology, 9. https:\/\/doi.org\/10.3389\/FONC.2019.00159","DOI":"10.3389\/FONC.2019.00159"},{"issue":"21","key":"10426_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12935-020-01719-5","volume":"211","author":"A Emami Nejad","year":"2021","unstructured":"Emami Nejad, A., Najafgholian, S., Rostami, A., et al. (2021). (2021) The role of hypoxia in the tumor microenvironment and development of cancer stem cell: A novel approach to developing treatment. Cancer Cell International, 211(21), 1\u201326. https:\/\/doi.org\/10.1186\/S12935-020-01719-5","journal-title":"Cancer Cell International"},{"key":"10426_CR154","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/J.GENDIS.2016.11.003","volume":"4","author":"X Lv","year":"2017","unstructured":"Lv, X., Li, J., Zhang, C., et al. (2017). The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism. Genes Dis, 4, 19\u201324. https:\/\/doi.org\/10.1016\/J.GENDIS.2016.11.003","journal-title":"Genes Dis"},{"issue":"20","key":"10426_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12943-020-01288-1","volume":"201","author":"X Wei","year":"2021","unstructured":"Wei, X., Chen, Y., Jiang, X., et al. (2021). (2021) Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Molecular Cancer, 201(20), 1\u201318. https:\/\/doi.org\/10.1186\/S12943-020-01288-1","journal-title":"Molecular Cancer"},{"key":"10426_CR156","doi-asserted-by":"publisher","unstructured":"Gong, P. J., Shao, Y. C., Huang, S. R., et al. (2020). Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer. Frontiers in Oncology, 10. https:\/\/doi.org\/10.3389\/FONC.2020.579868","DOI":"10.3389\/FONC.2020.579868"},{"key":"10426_CR157","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.7150\/THNO.26789","volume":"8","author":"Z Liu","year":"2018","unstructured":"Liu, Z., Wang, Y., Dou, C., et al. (2018). Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma. Theranostics, 8, 4649\u20134663. https:\/\/doi.org\/10.7150\/THNO.26789","journal-title":"Theranostics"},{"key":"10426_CR158","doi-asserted-by":"publisher","first-page":"7822","DOI":"10.1002\/CAM4.2667","volume":"8","author":"S Yoshimoto","year":"2019","unstructured":"Yoshimoto, S., Tanaka, F., Morita, H., et al. (2019). Hypoxia-induced HIF-1\u03b1 and ZEB1 are critical for the malignant transformation of ameloblastoma via TGF-\u03b2-dependent EMT. Cancer Medicine, 8, 7822\u20137832. https:\/\/doi.org\/10.1002\/CAM4.2667","journal-title":"Cancer Medicine"},{"key":"10426_CR159","doi-asserted-by":"publisher","unstructured":"Su, Q., Fan, M., Wang, J., et al. (2019). Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1\u03b1\/TGF-\u03b2 feed-forward loop in hepatocellular carcinoma. Cell Death & Disease, 10. https:\/\/doi.org\/10.1038\/S41419-019-2173-1","DOI":"10.1038\/S41419-019-2173-1"},{"key":"10426_CR160","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/JCP.29111","volume":"235","author":"X Xiong","year":"2020","unstructured":"Xiong, X., Sun, Y., & Wang, X. (2020). HIF1A\/miR-20a-5p\/TGF\u03b21 axis modulates adipose-derived stem cells in a paracrine manner to affect the angiogenesis of human dermal microvascular endothelial cells. Journal of Cellular Physiology, 235, 2091\u20132101. https:\/\/doi.org\/10.1002\/JCP.29111","journal-title":"Journal of Cellular Physiology"},{"key":"10426_CR161","doi-asserted-by":"publisher","first-page":"29363","DOI":"10.1021\/ACSAMI.1C07103\/ASSET\/IMAGES\/LARGE\/AM1C07103_0010.JPEG","volume":"13","author":"L Pang","year":"2021","unstructured":"Pang, L., Tian, P., Cui, X., et al. (2021). In Situ Photo-Cross-Linking Hydrogel Accelerates Diabetic Wound Healing through Restored Hypoxia-Inducible Factor 1-Alpha Pathway and Regulated Inflammation. ACS Applied Materials & Interfaces, 13, 29363\u201329379. https:\/\/doi.org\/10.1021\/ACSAMI.1C07103\/ASSET\/IMAGES\/LARGE\/AM1C07103_0010.JPEG","journal-title":"ACS Applied Materials & Interfaces"},{"key":"10426_CR162","doi-asserted-by":"publisher","unstructured":"De Francesco, E. M., Maggiolini, M., Musti, A. M. (2018). Crosstalk between Notch, HIF-1\u03b1 and GPER in Breast Cancer EMT. International Journal of Molecular Sciences, 19. https:\/\/doi.org\/10.3390\/IJMS19072011","DOI":"10.3390\/IJMS19072011"},{"key":"10426_CR163","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1111\/JCMM.14241","volume":"23","author":"HS Zhang","year":"2019","unstructured":"Zhang, H. S., Zhang, Z. G., Du, G. Y., et al. (2019). Nrf2 promotes breast cancer cell migration via up-regulation of G6PD\/HIF-1\u03b1\/Notch1 axis. Journal of Cellular and Molecular Medicine, 23, 3451\u20133463. https:\/\/doi.org\/10.1111\/JCMM.14241","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10426_CR164","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4149\/NEO_2019_190121N61","volume":"67","author":"ZZ Liu","year":"2020","unstructured":"Liu, Z. Z., Tian, Y. F., Wu, H., et al. (2020). LncRNA H19 promotes glioma angiogenesis through miR-138\/HIF-1\u03b1\/VEGF axis. Neoplasma, 67, 111\u2013118. https:\/\/doi.org\/10.4149\/NEO_2019_190121N61","journal-title":"Neoplasma"},{"key":"10426_CR165","doi-asserted-by":"publisher","first-page":"7681","DOI":"10.1007\/S00018-021-03950-3","volume":"78","author":"YH Huang","year":"2021","unstructured":"Huang, Y. H., Kuo, C. H., Peng, I. C., et al. (2021). Recombinant thrombomodulin domain 1 rescues pathological angiogenesis by inhibition of HIF-1\u03b1-VEGF pathway. Cellular and Molecular Life Sciences, 78, 7681\u20137692. https:\/\/doi.org\/10.1007\/S00018-021-03950-3","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10426_CR166","doi-asserted-by":"publisher","unstructured":"Xu, Z., Zhu, C., Chen, C., et al. (2018). CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met\/ERK\/Elk-1\/HIF-1\u03b1\/VEGF-A pathway in colorectal cancer. Cell Death & Disease, 9. https:\/\/doi.org\/10.1038\/S41419-018-1010-2","DOI":"10.1038\/S41419-018-1010-2"},{"key":"10426_CR167","doi-asserted-by":"publisher","unstructured":"Hong, J., Kim, Y., Yanpallewar, S., Charles Lin, P. (2020). The Rho\/Rac Guanine Nucleotide Exchange Factor Vav1 Regulates Hif-1\u03b1 and Glut-1 Expression and Glucose Uptake in the Brain. International Journal of Molecular Sciences, 21. https:\/\/doi.org\/10.3390\/IJMS21041341","DOI":"10.3390\/IJMS21041341"},{"key":"10426_CR168","doi-asserted-by":"publisher","first-page":"333","DOI":"10.11817\/J.ISSN.1672-7347.2021.200010","volume":"46","author":"W Tang","year":"2021","unstructured":"Tang, W., Long, T., Li, F., et al. (2021). HIF - 1 \u03b1 may promote glycolysis in psoriasis vulgaris via upregulation of CD147 and GLUT1. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 46, 333\u2013344. https:\/\/doi.org\/10.11817\/J.ISSN.1672-7347.2021.200010","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10426_CR169","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/FCELL.2019.00004\/BIBTEX","volume":"7","author":"W Al Tameemi","year":"2019","unstructured":"Al Tameemi, W., Dale, T. P., Al-Jumaily, R. M. K., & Forsyth, N. R. (2019). Hypoxia-Modified Cancer Cell Metabolism. Frontiers in Cell and Developmental Biology, 7, 4. https:\/\/doi.org\/10.3389\/FCELL.2019.00004\/BIBTEX","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10426_CR170","doi-asserted-by":"publisher","unstructured":"Carrasco-Pozo, C., Tan, K. N., Rodriguez, T., Avery, V. M. (2019). The Molecular Effects of Sulforaphane and Capsaicin on Metabolism upon Androgen and Tip60 Activation of Androgen Receptor. International Journal of Molecular Sciences, 20. https:\/\/doi.org\/10.3390\/IJMS20215384","DOI":"10.3390\/IJMS20215384"},{"key":"10426_CR171","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1111\/CAS.14614","volume":"111","author":"S Ikeda","year":"2020","unstructured":"Ikeda, S., Abe, F., Matsuda, Y., et al. (2020). Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myeloma. Cancer Science, 111, 4088\u20134101. https:\/\/doi.org\/10.1111\/CAS.14614","journal-title":"Cancer Science"},{"key":"10426_CR172","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/J.APSB.2021.09.019","volume":"12","author":"D Du","year":"2022","unstructured":"Du, D., Liu, C., Qin, M., et al. (2022). Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharmaceutica Sinica B, 12, 558\u2013580. https:\/\/doi.org\/10.1016\/J.APSB.2021.09.019","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10426_CR173","doi-asserted-by":"publisher","unstructured":"Tse, A. P. W., Sze, K. M. F., Shea, Q. T. K., et al. (2018). Hepatitis transactivator protein X promotes extracellular matrix modification through HIF\/LOX pathway in liver cancer. Oncogenesis, 7. https:\/\/doi.org\/10.1038\/S41389-018-0052-8","DOI":"10.1038\/S41389-018-0052-8"},{"key":"10426_CR174","doi-asserted-by":"publisher","unstructured":"Li, Z., Shi, L., Li, X., et al. (2021). RNF144A-AS1, a TGF-\u03b21- and hypoxia-inducible gene that promotes tumor metastasis and proliferation via targeting the miR-30c-2-3p\/LOX axis in gastric cancer. Cell & Bioscience, 11. https:\/\/doi.org\/10.1186\/S13578-021-00689-Z","DOI":"10.1186\/S13578-021-00689-Z"},{"key":"10426_CR175","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/S41417-020-00279-0","volume":"28","author":"M Murdocca","year":"2021","unstructured":"Murdocca, M., De Masi, C., Pucci, S., et al. (2021). LOX-1 and cancer: An indissoluble liaison. Cancer Gene Therapy, 28, 1088\u20131098. https:\/\/doi.org\/10.1038\/S41417-020-00279-0","journal-title":"Cancer Gene Therapy"},{"key":"10426_CR176","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3904\/KJIM.2016.302","volume":"32","author":"CD Yeo","year":"2017","unstructured":"Yeo, C. D., Kang, N., Choi, S. Y., et al. (2017). The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: A possible link to epigenetic regulation. Korean Journal of Internal Medicine, 32, 589\u2013599. https:\/\/doi.org\/10.3904\/KJIM.2016.302","journal-title":"Korean Journal of Internal Medicine"},{"key":"10426_CR177","doi-asserted-by":"publisher","unstructured":"Dong, W., Kong, M., Zhu, Y., et al. (2020). Activation of TWIST Transcription by Chromatin Remodeling Protein BRG1 Contributes to Liver Fibrosis in Mice. Frontiers in Cell and Developmental Biology, 8. https:\/\/doi.org\/10.3389\/FCELL.2020.00340","DOI":"10.3389\/FCELL.2020.00340"},{"key":"10426_CR178","doi-asserted-by":"publisher","unstructured":"Wang, Q., He, Z., Huang, M., et al. (2018). Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2\u03b1. Nature Communications, 9. https:\/\/doi.org\/10.1038\/S41467-018-03050-0","DOI":"10.1038\/S41467-018-03050-0"},{"key":"10426_CR179","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/J.YMTHE.2019.05.017","volume":"27","author":"K Xu","year":"2019","unstructured":"Xu, K., Zhan, Y., Yuan, Z., et al. (2019). Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1\u03b1\/miR-338-5p\/IL-6 Feedback Loop. Molecular Therapy, 27, 1810\u20131824. https:\/\/doi.org\/10.1016\/J.YMTHE.2019.05.017","journal-title":"Molecular Therapy"},{"key":"10426_CR180","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1111\/JCMM.15056","volume":"24","author":"Q Su","year":"2020","unstructured":"Su, Q., Wang, J., Fan, M., et al. (2020). Sanguinarine disrupts the colocalization and interaction of HIF-1\u03b1 with tyrosine and serine phosphorylated-STAT3 in breast cancer. Journal of Cellular and Molecular Medicine, 24, 3756\u20133761. https:\/\/doi.org\/10.1111\/JCMM.15056","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10426_CR181","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/J.APSB.2020.10.022","volume":"11","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Fan, J., Zeng, X., et al. (2021). Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment. Acta Pharmaceutica Sinica B, 11, 609\u2013620. https:\/\/doi.org\/10.1016\/J.APSB.2020.10.022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10426_CR182","doi-asserted-by":"publisher","unstructured":"Yang, X., Zheng, Y., Tan, J., et al. (2021). MiR-199a-5p-HIF-1\u03b1-STAT3 Positive Feedback Loop Contributes to the Progression of Non-Small Cell Lung Cancer. Frontiers in Cell and Developmental Biology, 8. https:\/\/doi.org\/10.3389\/FCELL.2020.620615","DOI":"10.3389\/FCELL.2020.620615"},{"key":"10426_CR183","doi-asserted-by":"publisher","unstructured":"Cao, J., Li, L., Xiong, L., et al. (2022). Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking. Phytomedicine Plus : International Journal of Phytotherapy and Phytopharmacology, 2. https:\/\/doi.org\/10.1016\/J.PHYPLU.2022.100252","DOI":"10.1016\/J.PHYPLU.2022.100252"},{"key":"10426_CR184","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.26355\/EURREV_201806_15175","volume":"22","author":"Z Liang","year":"2018","unstructured":"Liang, Z., Chi, Y. J., Lin, G. Q., et al. (2018). MiRNA-26a promotes angiogenesis in a rat model of cerebral infarction via PI3K\/AKT and MAPK\/ERK pathway. European Review for Medical and Pharmacological Sciences, 22, 3485\u20133492. https:\/\/doi.org\/10.26355\/EURREV_201806_15175","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10426_CR185","doi-asserted-by":"publisher","unstructured":"Xu, X., You, K., Bu, R. (2019). Proximal Tubular Development Is Impaired with Downregulation of MAPK\/ERK Signaling, HIF-1 \u03b1, and Catalase by Hyperoxia Exposure in Neonatal Rats. Oxidative Medicine and Cellular Longevity, 2019. https:\/\/doi.org\/10.1155\/2019\/9219847","DOI":"10.1155\/2019\/9219847"},{"key":"10426_CR186","doi-asserted-by":"publisher","unstructured":"Russignan, A., Dal Collo, G., Bagnato, A., et al. (2021). Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma. Frontiers in Oncology, 10. https:\/\/doi.org\/10.3389\/FONC.2020.600025","DOI":"10.3389\/FONC.2020.600025"},{"key":"10426_CR187","doi-asserted-by":"publisher","unstructured":"Wang, P., Zhao, L., Gong, S., et al. (2021). HIF1\u03b1\/HIF2\u03b1-Sox2\/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K\/AKT signalling pathway with positive feedback under hypoxia. Cell Death & Disease 12. https:\/\/doi.org\/10.1038\/S41419-021-03598-8","DOI":"10.1038\/S41419-021-03598-8"},{"key":"10426_CR188","doi-asserted-by":"publisher","unstructured":"Wang, Y., Bibi, M., Min, P., et al. (2019). SOX2 promotes hypoxia-induced breast cancer cell migration by inducing NEDD9 expression and subsequent activation of Rac1\/HIF-1\u03b1 signaling. Cellular & Molecular Biology Letters, 24. https:\/\/doi.org\/10.1186\/S11658-019-0180-Y","DOI":"10.1186\/S11658-019-0180-Y"},{"key":"10426_CR189","doi-asserted-by":"publisher","unstructured":"Chen, G., Liu, B., Yin, S., et al. (2020). Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA. Oncogenesis, 9. https:\/\/doi.org\/10.1038\/S41389-020-00265-Z","DOI":"10.1038\/S41389-020-00265-Z"},{"key":"10426_CR190","doi-asserted-by":"publisher","unstructured":"Li, Q., Sun, H., Luo, D., et al. (2021). Lnc-RP11\u2013536 K7.3\/SOX2\/HIF-1\u03b1 signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids. Journal of Experimental & Clinical Cancer Research, 40. https:\/\/doi.org\/10.1186\/S13046-021-02143-X","DOI":"10.1186\/S13046-021-02143-X"},{"key":"10426_CR191","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/J.STEMCR.2017.12.003","volume":"10","author":"YC Kuo","year":"2018","unstructured":"Kuo, Y. C., Au, H. K., Hsu, J. L., et al. (2018). IGF-1R Promotes Symmetric Self-Renewal and Migration of Alkaline Phosphatase + Germ Stem Cells through HIF-2\u03b1-OCT4\/CXCR4 Loop under Hypoxia. Stem Cell Reports, 10, 524\u2013537. https:\/\/doi.org\/10.1016\/J.STEMCR.2017.12.003","journal-title":"Stem Cell Reports"},{"key":"10426_CR192","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3892\/IJO.2020.5097","volume":"57","author":"Z Jiang","year":"2020","unstructured":"Jiang, Z., Zhang, C., Liu, X., et al. (2020). Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF-1\u03b1 and Oct4. International Journal of Oncology, 57, 780\u2013790. https:\/\/doi.org\/10.3892\/IJO.2020.5097","journal-title":"International Journal of Oncology"},{"key":"10426_CR193","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1172\/JCI138577","volume":"130","author":"H Lu","year":"2020","unstructured":"Lu, H., Xie, Y., Tran, L., et al. (2020). Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness. The Journal of Clinical Investigation, 130, 4607\u20134623. https:\/\/doi.org\/10.1172\/JCI138577","journal-title":"The Journal of Clinical Investigation"},{"key":"10426_CR194","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.7150\/THNO.19988","volume":"7","author":"Y Jiang","year":"2017","unstructured":"Jiang, Y., Mao, C., Yang, R., et al. (2017). EGLN1\/c-Myc Induced Lymphoid-Specific Helicase Inhibits Ferroptosis through Lipid Metabolic Gene Expression Changes. Theranostics, 7, 3293\u20133305. https:\/\/doi.org\/10.7150\/THNO.19988","journal-title":"Theranostics"},{"key":"10426_CR195","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/S12253-018-0479-4","volume":"25","author":"L Boldrini","year":"2019","unstructured":"Boldrini, L., Bartoletti, R., Giordano, M., et al. (2019). C-MYC, HIF-1\u03b1, ERG, TKT, and GSTP1: An Axis in Prostate Cancer? Pathology Oncology Research, 25, 1423\u20131429. https:\/\/doi.org\/10.1007\/S12253-018-0479-4","journal-title":"Pathology Oncology Research"},{"key":"10426_CR196","doi-asserted-by":"publisher","unstructured":"Liu, X., Zhou, Y., Peng, J., et al. (2020). Silencing c-Myc Enhances the Antitumor Activity of Bufalin by Suppressing the HIF-1\u03b1\/SDF-1\/CXCR4 Pathway in Pancreatic Cancer Cells. Frontiers in Pharmacology, 11. https:\/\/doi.org\/10.3389\/FPHAR.2020.00495","DOI":"10.3389\/FPHAR.2020.00495"},{"key":"10426_CR197","doi-asserted-by":"publisher","unstructured":"Li, Y., Sun, X. X., Qian, D. Z., Dai, M. S. (2020). Molecular Crosstalk Between MYC and HIF in Cancer. Frontiers in Cell and Developmental Biology, 8. https:\/\/doi.org\/10.3389\/FCELL.2020.590576","DOI":"10.3389\/FCELL.2020.590576"},{"key":"10426_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13046-019-1384-8\/FIGURES\/7","volume":"38","author":"Y Mao","year":"2019","unstructured":"Mao, Y., Wang, Y., Dong, L., et al. (2019). Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells. Journal of Experimental & Clinical Cancer Research, 38, 1\u201314. https:\/\/doi.org\/10.1186\/S13046-019-1384-8\/FIGURES\/7","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10426_CR199","doi-asserted-by":"publisher","unstructured":"Li, C., Teixeira, A. F., Zhu, H. J., ten Dijke, P. (2021). Cancer associated-fibroblast-derived exosomes in cancer progression. Molecular Cancer, 20. https:\/\/doi.org\/10.1186\/S12943-021-01463-Y","DOI":"10.1186\/S12943-021-01463-Y"},{"key":"10426_CR200","doi-asserted-by":"publisher","first-page":"42","DOI":"10.20517\/2394-4722.2020.79","volume":"6","author":"A Von Schulze","year":"2020","unstructured":"Von Schulze, A., & Deng, F. (2020). A review on exosome-based cancer therapy. Journal of Cancer Metastasis and Treatment, 6, 42. https:\/\/doi.org\/10.20517\/2394-4722.2020.79","journal-title":"Journal of Cancer Metastasis and Treatment"},{"key":"10426_CR201","doi-asserted-by":"publisher","unstructured":"Giacobino, C., Canta, M., Fornaguera, C., et al. (2021). Extracellular Vesicles and Their Current Role in Cancer Immunotherapy. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/CANCERS13092280","DOI":"10.3390\/CANCERS13092280"},{"key":"10426_CR202","doi-asserted-by":"publisher","unstructured":"Lodestijn, S. C., Miedema, D. M., Lenos, K. J., et al. (2021). Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer. Cell Reports, 37. https:\/\/doi.org\/10.1016\/J.CELREP.2021.109852","DOI":"10.1016\/J.CELREP.2021.109852"},{"key":"10426_CR203","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.3389\/FIMMU.2020.02166\/BIBTEX","volume":"11","author":"A Sistigu","year":"2020","unstructured":"Sistigu, A., Musella, M., Galassi, C., et al. (2020). Tuning Cancer Fate: Tumor Microenvironment\u2019s Role in Cancer Stem Cell Quiescence and Reawakening. Frontiers in Immunology, 11, 2166. https:\/\/doi.org\/10.3389\/FIMMU.2020.02166\/BIBTEX","journal-title":"Frontiers in Immunology"},{"key":"10426_CR204","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.4252\/WJSC.V12.I11.1307","volume":"12","author":"M Luo","year":"2020","unstructured":"Luo, M., Li, J. F., Yang, Q., et al. (2020). Stem cell quiescence and its clinical relevance. World Journal of Stem Cells, 12, 1307. https:\/\/doi.org\/10.4252\/WJSC.V12.I11.1307","journal-title":"World Journal of Stem Cells"},{"issue":"12","key":"10426_CR205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-04116-6","volume":"129","author":"K Chen","year":"2021","unstructured":"Chen, K., Zhang, C., Ling, S., et al. (2021). The metabolic flexibility of quiescent CSC: Implications for chemotherapy resistance. Cell Death & Disease, 129(12), 1\u201312. https:\/\/doi.org\/10.1038\/s41419-021-04116-6","journal-title":"Cell Death & Disease"},{"key":"10426_CR206","doi-asserted-by":"publisher","first-page":"684","DOI":"10.20517\/CDR.2021.32","volume":"4","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Steed, A., Co, M., & Chen, X. (2021). Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer. Cancer Drug Resistance, 4, 684\u2013709. https:\/\/doi.org\/10.20517\/CDR.2021.32","journal-title":"Cancer Drug Resistance"},{"key":"10426_CR207","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/J.SEMCANCER.2021.04.021","volume":"78","author":"S Basu","year":"2022","unstructured":"Basu, S., Dong, Y., Kumar, R., et al. (2022). Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis. Seminars in Cancer Biology, 78, 90\u2013103. https:\/\/doi.org\/10.1016\/J.SEMCANCER.2021.04.021","journal-title":"Seminars in Cancer Biology"},{"key":"10426_CR208","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3389\/FONC.2019.00626\/BIBTEX","volume":"9","author":"ML De Angelis","year":"2019","unstructured":"De Angelis, M. L., Francescangeli, F., La Torre, F., & Zeuner, A. (2019). Stem cell plasticity and dormancy in the development of cancer therapy resistance. Frontiers in Oncology, 9, 626. https:\/\/doi.org\/10.3389\/FONC.2019.00626\/BIBTEX","journal-title":"Frontiers in Oncology"},{"key":"10426_CR209","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E., & Clevers, H. (2017). Cancer stem cells revisited. Nature Medicine, 23, 1124\u20131134. https:\/\/doi.org\/10.1038\/nm.4409","journal-title":"Nature Medicine"},{"key":"10426_CR210","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.2174\/1389450119666180326122831","volume":"19","author":"R Awasthi","year":"2018","unstructured":"Awasthi, R., Roseblade, A., Hansbro, P. M., et al. (2018). Nanoparticles in Cancer Treatment: Opportunities and Obstacles. Current Drug Targets, 19, 1696\u20131709. https:\/\/doi.org\/10.2174\/1389450119666180326122831","journal-title":"Current Drug Targets"},{"key":"10426_CR211","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.2217\/nnm-2018-0443","volume":"14","author":"A Reda","year":"2019","unstructured":"Reda, A., Hosseiny, S., & El-Sherbiny, I. M. (2019). Next-generation nanotheranostics targeting cancer stem cells. Nanomedicine, 14, 2487\u20132514. https:\/\/doi.org\/10.2217\/nnm-2018-0443","journal-title":"Nanomedicine"},{"key":"10426_CR212","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.18632\/oncotarget.4037","volume":"6","author":"A Mitra","year":"2015","unstructured":"Mitra, A., Mishra, L., & Li, S. (2015). EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget, 6, 10697\u201310711. https:\/\/doi.org\/10.18632\/oncotarget.4037","journal-title":"Oncotarget"},{"key":"10426_CR213","doi-asserted-by":"publisher","unstructured":"Seebacher, N. A., Krchniakova, M., Stacy, A. E., et al. (2021). Tumour Microenvironment Stress Promotes the Development of Drug Resistance. Antioxidants 10. https:\/\/doi.org\/10.3390\/ANTIOX10111801","DOI":"10.3390\/ANTIOX10111801"},{"key":"10426_CR214","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s12015-020-10031-8","volume":"16","author":"SH Lee","year":"2020","unstructured":"Lee, S. H., Reed-Newman, T., Anant, S., & Ramasamy, T. S. (2020). Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells. Stem Cell Reviews and Reports, 16, 1185\u20131207. https:\/\/doi.org\/10.1007\/s12015-020-10031-8","journal-title":"Stem Cell Reviews and Reports"},{"key":"10426_CR215","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013). Cancer drug resistance: An evolving paradigm. Nature Reviews Cancer, 13, 714\u2013726. https:\/\/doi.org\/10.1038\/nrc3599","journal-title":"Nature Reviews Cancer"},{"key":"10426_CR216","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00966-3","volume":"13","author":"J L\u00f3pez de Andr\u00e9s","year":"2020","unstructured":"L\u00f3pez de Andr\u00e9s, J., Gri\u00f1\u00e1n-Lis\u00f3n, C., Jim\u00e9nez, G., & Marchal, J. A. (2020). Cancer stem cell secretome in the tumor microenvironment: A key point for an effective personalized cancer treatment. Journal of Hematology & Oncology, 13, 1\u201322. https:\/\/doi.org\/10.1186\/s13045-020-00966-3","journal-title":"Journal of Hematology & Oncology"},{"key":"10426_CR217","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","volume":"7","author":"Y Yao","year":"2020","unstructured":"Yao, Y., Zhou, Y., Liu, L., et al. (2020). Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Frontiers in Molecular Biosciences, 7, 193. https:\/\/doi.org\/10.3389\/fmolb.2020.00193","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10426_CR218","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/978-1-4614-7876-8_23","volume":"9781461478","author":"JY Yhee","year":"2013","unstructured":"Yhee, J. Y., Son, S., Son, S., et al. (2013). The EPR effect in cancer therapy. Cancer Targeted Drug Delivery: An Elusive Dream, 9781461478, 621\u2013632. https:\/\/doi.org\/10.1007\/978-1-4614-7876-8_23","journal-title":"Cancer Targeted Drug Delivery: An Elusive Dream"},{"key":"10426_CR219","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.7150\/thno.49577","volume":"10","author":"Y Shi","year":"2020","unstructured":"Shi, Y., van der Meel, R., Chen, X., & Lammers, T. (2020). The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. Theranostics, 10, 7921\u20137924. https:\/\/doi.org\/10.7150\/thno.49577","journal-title":"Theranostics"},{"key":"10426_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-017-0004-3","volume":"3","author":"S Senapati","year":"2018","unstructured":"Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018). Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduction and Targeted Therapy, 3, 1\u201319. https:\/\/doi.org\/10.1038\/s41392-017-0004-3","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10426_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/916254","volume":"2013","author":"VR Muzykantov","year":"2013","unstructured":"Muzykantov, V. R. (2013). Targeted Drug Delivery to Endothelial Adhesion Molecules. ISRN Vasc Med, 2013, 1\u201327. https:\/\/doi.org\/10.1155\/2013\/916254","journal-title":"ISRN Vasc Med"},{"key":"10426_CR222","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.3390\/ijms20235819","volume":"20","author":"Y Sakurai","year":"2019","unstructured":"Sakurai, Y., Akita, H., & Harashima, H. (2019). Targeting tumor endothelial cells with nanoparticles. International Journal of Molecular Sciences, 20, 5819. https:\/\/doi.org\/10.3390\/ijms20235819","journal-title":"International Journal of Molecular Sciences"},{"key":"10426_CR223","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","volume":"66","author":"N Bertrand","year":"2014","unstructured":"Bertrand, N., Wu, J., Xu, X., et al. (2014). Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews, 66, 2\u201325. https:\/\/doi.org\/10.1016\/j.addr.2013.11.009","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10426_CR224","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nmat3776","volume":"12","author":"S Mura","year":"2013","unstructured":"Mura, S., Nicolas, J., & Couvreur, P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nature Materials, 12, 991\u20131003. https:\/\/doi.org\/10.1038\/nmat3776","journal-title":"Nature Materials"},{"key":"10426_CR225","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/thno.34576","volume":"9","author":"CA Cheng","year":"2019","unstructured":"Cheng, C. A., Deng, T., Lin, F. C., et al. (2019). Supramolecular nanomachines as stimuli-responsive gatekeepers on mesoporous silica nanoparticles for antibiotic and cancer drug delivery. Theranostics, 9, 3341\u20133364. https:\/\/doi.org\/10.7150\/thno.34576","journal-title":"Theranostics"},{"key":"10426_CR226","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fmolb.2020.610533","volume":"7","author":"RG Thomas","year":"2020","unstructured":"Thomas, R. G., Surendran, S. P., & Jeong, Y. Y. (2020). Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy. Frontiers in Molecular Biosciences, 7, 414. https:\/\/doi.org\/10.3389\/fmolb.2020.610533","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10426_CR227","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-03705-y","volume":"9","author":"D Rosenblum","year":"2018","unstructured":"Rosenblum, D., Joshi, N., Tao, W., et al. (2018). Progress and challenges towards targeted delivery of cancer therapeutics. Nature Communications, 9, 1\u201312. https:\/\/doi.org\/10.1038\/s41467-018-03705-y","journal-title":"Nature Communications"},{"key":"10426_CR228","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jconrel.2013.05.025","volume":"172","author":"MA Dobrovolskaia","year":"2013","unstructured":"Dobrovolskaia, M. A., & McNeil, S. E. (2013). Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. Journal of Controlled Release, 172, 456\u2013466. https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.025","journal-title":"Journal of Controlled Release"},{"key":"10426_CR229","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1546","volume":"11","author":"P Urb\u00e1n","year":"2019","unstructured":"Urb\u00e1n, P., Liptrott, N. J., & Bremer, S. (2019). Overview of the blood compatibility of nanomedicines: A trend analysis of in vitro and in vivo studies. Wiley Interdisciplinary Reviews Nanomedicine Nanobiotechnology, 11, e1546. https:\/\/doi.org\/10.1002\/wnan.1546","journal-title":"Wiley Interdisciplinary Reviews Nanomedicine Nanobiotechnology"},{"key":"10426_CR230","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fimmu.2017.00472","volume":"8","author":"Y Li","year":"2017","unstructured":"Li, Y., Fujita, M., & Boraschi, D. (2017). Endotoxin contamination in nanomaterials leads to the misinterpretation of immunosafety results. Frontiers in Immunology, 8, 472. https:\/\/doi.org\/10.3389\/fimmu.2017.00472","journal-title":"Frontiers in Immunology"},{"key":"10426_CR231","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.comtox.2016.07.001","volume":"1","author":"K Gerloff","year":"2017","unstructured":"Gerloff, K., Landesmann, B., Worth, A., et al. (2017). The Adverse Outcome Pathway approach in nanotoxicology. Comput Toxicol, 1, 3\u201311. https:\/\/doi.org\/10.1016\/j.comtox.2016.07.001","journal-title":"Comput Toxicol"},{"key":"10426_CR232","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41401-020-0424-4","volume":"41","author":"B Sun","year":"2020","unstructured":"Sun, B., Hyun, H., Li, L. tao, & Wang, A. Z. (2020). Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment. Acta Pharmacologica Sinica, 41, 970\u2013985. https:\/\/doi.org\/10.1038\/s41401-020-0424-4","journal-title":"Acta Pharmacologica Sinica"},{"key":"10426_CR233","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.7150\/thno.42998","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Guo, J., & Huang, L. (2020). Modulation of tumor microenvironment for immunotherapy: Focus on nanomaterial-based strategies. Theranostics, 10, 3099\u20133117. https:\/\/doi.org\/10.7150\/thno.42998","journal-title":"Theranostics"},{"key":"10426_CR234","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/S12951-022-01442-5","volume":"20","author":"R Zhang","year":"2022","unstructured":"Zhang, R., Liu, T., Li, W., et al. (2022). Tumor microenvironment-responsive BSA nanocarriers for combined chemo\/chemodynamic cancer therapy. J Nanobiotechnology, 20, 223. https:\/\/doi.org\/10.1186\/S12951-022-01442-5","journal-title":"J Nanobiotechnology"},{"key":"10426_CR235","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jconrel.2014.03.050","volume":"190","author":"AC Anselmo","year":"2014","unstructured":"Anselmo, A. C., & Mitragotri, S. (2014). Cell-mediated delivery of nanoparticles: Taking advantage of circulatory cells to target nanoparticles. Journal of Controlled Release, 190, 531\u2013541. https:\/\/doi.org\/10.1016\/j.jconrel.2014.03.050","journal-title":"Journal of Controlled Release"},{"key":"10426_CR236","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann, I. K., Wood, M. J. A., & Fuhrmann, G. (2021). Extracellular vesicles as a next-generation drug delivery platform. Nature Nanotechnology, 16, 748\u2013759. https:\/\/doi.org\/10.1038\/s41565-021-00931-2","journal-title":"Nature Nanotechnology"},{"key":"10426_CR237","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.tcb.2016.11.003","volume":"27","author":"SLN Maas","year":"2017","unstructured":"Maas, S. L. N., Breakefield, X. O., & Weaver, A. M. (2017). Extracellular Vesicles: Unique Intercellular Delivery Vehicles. Trends in Cell Biology, 27, 172\u2013188. https:\/\/doi.org\/10.1016\/j.tcb.2016.11.003","journal-title":"Trends in Cell Biology"},{"key":"10426_CR238","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/FBIOE.2022.882545","volume":"0","author":"MC Sanmartin","year":"2022","unstructured":"Sanmartin, M. C., Borzone, F. R., Giorello, M. B., et al. (2022). Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy. Frontiers in Bioengineering and Biotechnology, 0, 579. https:\/\/doi.org\/10.3389\/FBIOE.2022.882545","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"10426_CR239","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1002\/cam4.2148","volume":"8","author":"M Sedighi","year":"2019","unstructured":"Sedighi, M., Zahedi Bialvaei, A., Hamblin, M. R., et al. (2019). Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities. Cancer Medicine, 8, 3167\u20133181. https:\/\/doi.org\/10.1002\/cam4.2148","journal-title":"Cancer Medicine"},{"key":"10426_CR240","doi-asserted-by":"publisher","unstructured":"Gao, C., Wang, Q., Li, J., et al. (2022). In vivo hitchhiking of immune cells by intracellular self-assembly of bacteria-mimetic nanomedicine for targeted therapy of melanoma. Science Advances, 8. https:\/\/doi.org\/10.1126\/SCIADV.ABN1805","DOI":"10.1126\/SCIADV.ABN1805"},{"key":"10426_CR241","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/acs.chemrev.0c00779","volume":"121","author":"M Izci","year":"2021","unstructured":"Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021). The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors. Chemical Reviews, 121, 1746\u20131803. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00779","journal-title":"Chemical Reviews"},{"key":"10426_CR242","doi-asserted-by":"publisher","first-page":"18504","DOI":"10.18632\/oncotarget.4181","volume":"6","author":"SK Basak","year":"2015","unstructured":"Basak, S. K., Zinabadi, A., Wu, A. W., et al. (2015). Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells. Oncotarget, 6, 18504\u201318517. https:\/\/doi.org\/10.18632\/oncotarget.4181","journal-title":"Oncotarget"},{"key":"10426_CR243","doi-asserted-by":"publisher","unstructured":"Lu, B., Huang, X., Mo, J, Zhao, W. (2016). Drug delivery using nanoparticles for cancer stem-like cell targeting. Frontiers in Pharmacology, 7. https:\/\/doi.org\/10.3389\/fphar.2016.00084","DOI":"10.3389\/fphar.2016.00084"},{"key":"10426_CR244","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fcell.2020.00082","volume":"8","author":"F Chiacchiera","year":"2020","unstructured":"Chiacchiera, F., Morey, L., & Mozzetta, C. (2020). Editorial: Epigenetic Regulation of Stem Cell Plasticity in Tissue Regeneration and Disease. Front Cell Dev Biol, 8, 82. https:\/\/doi.org\/10.3389\/fcell.2020.00082","journal-title":"Front Cell Dev Biol"},{"key":"10426_CR245","doi-asserted-by":"publisher","unstructured":"Zhang, J., Arisha, A. H., Hua, J. (2021). Epigenetic regulation in stem cells. Epigenetics and Reproductive Health, 69\u201379. https:\/\/doi.org\/10.1016\/b978-0-12-819753-0.00004-0","DOI":"10.1016\/b978-0-12-819753-0.00004-0"},{"key":"10426_CR246","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-36251-0","volume":"8","author":"K Takeda","year":"2018","unstructured":"Takeda, K., Mizushima, T., Yokoyama, Y., et al. (2018). Sox2 is associated with cancer stem-like properties in colorectal cancer. Science and Reports, 8, 1\u20139. https:\/\/doi.org\/10.1038\/s41598-018-36251-0","journal-title":"Science and Reports"},{"key":"10426_CR247","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00242-3","volume":"5","author":"S Zhang","year":"2020","unstructured":"Zhang, S., Xiong, X., & Sun, Y. (2020). Functional characterization of SOX2 as an anticancer target. Signal Transduction and Targeted Therapy, 5, 1\u201317. https:\/\/doi.org\/10.1038\/s41392-020-00242-3","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10426_CR248","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/ijc.22508","volume":"120","author":"Y Atlasi","year":"2007","unstructured":"Atlasi, Y., Mowla, S. J., Ziaee, S. A. M., & Bahrami, A. R. (2007). OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. International Journal of Cancer, 120, 1598\u20131602. https:\/\/doi.org\/10.1002\/ijc.22508","journal-title":"International Journal of Cancer"},{"key":"10426_CR249","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.03.005","volume":"1866","author":"IS Mohiuddin","year":"2020","unstructured":"Mohiuddin, I. S., Wei, S. J., & Kang, M. H. (2020). Role of OCT4 in cancer stem-like cells and chemotherapy resistance. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1866, 165432. https:\/\/doi.org\/10.1016\/j.bbadis.2019.03.005","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10426_CR250","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1002\/stem.2007","volume":"33","author":"CR Jeter","year":"2015","unstructured":"Jeter, C. R., Yang, T., Wang, J., et al. (2015). Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions. Stem Cells, 33, 2381\u20132390. https:\/\/doi.org\/10.1002\/stem.2007","journal-title":"Stem Cells"},{"key":"10426_CR251","doi-asserted-by":"publisher","unstructured":"Gil-Kulik, P., Krzy\u017canowski, A., Dudzi\u0144ska, E., et al. (2019). Potential involvement of BIRC5 in maintaining pluripotency and cell differentiation of human stem cells. Oxidative Medicine and Cellular Longevity, 2019. https:\/\/doi.org\/10.1155\/2019\/8727925","DOI":"10.1155\/2019\/8727925"},{"key":"10426_CR252","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79736-7","volume":"11","author":"L Xu","year":"2021","unstructured":"Xu, L., Yu, W., Xiao, H., & Lin, K. (2021). BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration. Science and Reports, 11, 1\u201313. https:\/\/doi.org\/10.1038\/s41598-020-79736-7","journal-title":"Science and Reports"},{"key":"10426_CR253","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s12015-020-09995-4","volume":"16","author":"NM Warrier","year":"2020","unstructured":"Warrier, N. M., Agarwal, P., & Kumar, P. (2020). Emerging Importance of Survivin in Stem Cells and Cancer: The Development of New Cancer Therapeutics. Stem Cell Reviews and Reports, 16, 828\u2013852. https:\/\/doi.org\/10.1007\/s12015-020-09995-4","journal-title":"Stem Cell Reviews and Reports"},{"key":"10426_CR254","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/cas.12691","volume":"106","author":"J Neradil","year":"2015","unstructured":"Neradil, J., & Veselska, R. (2015). Nestin as a marker of cancer stem cells. Cancer Science, 106, 803\u2013811. https:\/\/doi.org\/10.1111\/cas.12691","journal-title":"Cancer Science"},{"key":"10426_CR255","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12282-012-0357-y","volume":"21","author":"T Nagata","year":"2014","unstructured":"Nagata, T., Shimada, Y., Sekine, S., et al. (2014). Prognostic significance of NANOG and KLF4 for breast cancer. Breast Cancer, 21, 96\u2013101. https:\/\/doi.org\/10.1007\/s12282-012-0357-y","journal-title":"Breast Cancer"},{"key":"10426_CR256","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-30168-4","volume":"8","author":"A Rasti","year":"2018","unstructured":"Rasti, A., Mehrazma, M., Madjd, Z., et al. (2018). Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas. Science and Reports, 8, 1\u201311. https:\/\/doi.org\/10.1038\/s41598-018-30168-4","journal-title":"Science and Reports"},{"key":"10426_CR257","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12885-016-2509-5","volume":"16","author":"IV Lundberg","year":"2016","unstructured":"Lundberg, I. V., Edin, S., Ekl\u00f6f, V., et al. (2016). SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer. BMC Cancer, 16, 471. https:\/\/doi.org\/10.1186\/s12885-016-2509-5","journal-title":"BMC Cancer"},{"key":"10426_CR258","doi-asserted-by":"publisher","first-page":"43540","DOI":"10.18632\/oncotarget.6183","volume":"6","author":"T Schaefer","year":"2015","unstructured":"Schaefer, T., Wang, H., Mir, P., et al. (2015). Molecular and functional interactions between AKT and SOX2 in breast carcinoma. Oncotarget, 6, 43540\u201343556. https:\/\/doi.org\/10.18632\/oncotarget.6183","journal-title":"Oncotarget"},{"key":"10426_CR259","doi-asserted-by":"publisher","unstructured":"Warrier, N. M., Agarwal, P., Kumar, P. (2021). Integrative Analysis to Identify Genes Associated with Stemness and Immune Infiltration in Glioblastoma. Cells, 10. https:\/\/doi.org\/10.3390\/CELLS10102765","DOI":"10.3390\/CELLS10102765"},{"key":"10426_CR260","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","volume":"24","author":"BC Prager","year":"2019","unstructured":"Prager, B. C., Xie, Q., Bao, S., & Rich, J. N. (2019). Cancer Stem Cells: The Architects of the Tumor Ecosystem. Cell Stem Cell, 24, 41\u201353. https:\/\/doi.org\/10.1016\/j.stem.2018.12.009","journal-title":"Cell Stem Cell"},{"key":"10426_CR261","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-017-0471-6","volume":"10","author":"SG Pai","year":"2017","unstructured":"Pai, S. G., Carneiro, B. A., Mota, J. M., et al. (2017). Wnt\/beta-catenin pathway: Modulating anticancer immune response. Journal of Hematology & Oncology, 10, 101. https:\/\/doi.org\/10.1186\/s13045-017-0471-6","journal-title":"Journal of Hematology & Oncology"},{"key":"10426_CR262","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21207697","volume":"21","author":"M Koni","year":"2020","unstructured":"Koni, M., Pinnar\u00f2, V., & Brizzi, M. F. (2020). The wnt signalling pathway: A tailored target in cancer. International Journal of Molecular Sciences, 21, 1\u201326. https:\/\/doi.org\/10.3390\/ijms21207697","journal-title":"International Journal of Molecular Sciences"},{"key":"10426_CR263","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.gendis.2015.12.004","volume":"3","author":"MK Mohammed","year":"2016","unstructured":"Mohammed, M. K., Shao, C., Wang, J., et al. (2016). Wnt\/\u03b2-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes & Diseases, 3, 11\u201340. https:\/\/doi.org\/10.1016\/j.gendis.2015.12.004","journal-title":"Genes & Diseases"},{"key":"10426_CR264","doi-asserted-by":"publisher","first-page":"9525","DOI":"10.18632\/oncotarget.6672","volume":"7","author":"J Luo","year":"2016","unstructured":"Luo, J., Wang, P., Wang, R., et al. (2016). The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma. Oncotarget, 7, 9525\u20139537. https:\/\/doi.org\/10.18632\/oncotarget.6672","journal-title":"Oncotarget"},{"key":"10426_CR265","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/sci.2018.02.02","volume":"5","author":"V Venkatesh","year":"2018","unstructured":"Venkatesh, V., Nataraj, R., Thangaraj, G. S., et al. (2018). Targeting notch signalling pathway of cancer stem cells. Stem Cell Investigation, 5, 5\u20135. https:\/\/doi.org\/10.21037\/sci.2018.02.02","journal-title":"Stem Cell Investigation"},{"key":"10426_CR266","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3390\/cancers7030851","volume":"7","author":"CR Cochrane","year":"2015","unstructured":"Cochrane, C. R., Szczepny, A., Watkins, D. N., & Cain, J. E. (2015). Hedgehog signaling in the maintenance of cancer stem cells. Cancers (Basel), 7, 1554\u20131585. https:\/\/doi.org\/10.3390\/cancers7030851","journal-title":"Cancers (Basel)"},{"key":"10426_CR267","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/cells5020016","volume":"5","author":"AL Rinkenbaugh","year":"2016","unstructured":"Rinkenbaugh, A. L., & Baldwin, A. S. (2016). The NF-\u03baB Pathway and Cancer Stem Cells. Cells, 5, 16. https:\/\/doi.org\/10.3390\/cells5020016","journal-title":"Cells"},{"key":"10426_CR268","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","volume":"2","author":"Y Xia","year":"2014","unstructured":"Xia, Y., Shen, S., & Verma, I. M. (2014). NF-\u03baB, an active player in human cancers. Cancer Immunology Research, 2, 823\u2013830. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0112","journal-title":"Cancer Immunology Research"},{"key":"10426_CR269","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/cancers11050655","volume":"11","author":"C Kaltschmidt","year":"2019","unstructured":"Kaltschmidt, C., Banz-Jansen, C., Benhidjeb, T., et al. (2019). A role for NF-\u03baB in organ specific cancer and cancer stem cells. Cancers (Basel), 11, 655. https:\/\/doi.org\/10.3390\/cancers11050655","journal-title":"Cancers (Basel)"},{"key":"10426_CR270","doi-asserted-by":"publisher","unstructured":"Hin Tang, J. J., Hao Thng, D. K., Lim, J. J., Toh, T. B. (2020). JAK\/STAT signaling in hepatocellular carcinoma. Hepatic Oncology, 7. https:\/\/doi.org\/10.2217\/hep-2020-0001","DOI":"10.2217\/hep-2020-0001"},{"key":"10426_CR271","doi-asserted-by":"publisher","unstructured":"Owen, K. L., Brockwell, N. K., Parker, B. S. (2019). Jak-stat signaling: A double-edged sword of immune regulation and cancer progression. Cancers (Basel), 11. https:\/\/doi.org\/10.3390\/cancers11122002","DOI":"10.3390\/cancers11122002"},{"key":"10426_CR272","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/bjc.2015.233","volume":"113","author":"SJ Thomas","year":"2015","unstructured":"Thomas, S. J., Snowden, J. A., Zeidler, M. P., & Danson, S. J. (2015). The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. British Journal of Cancer, 113, 365\u2013371. https:\/\/doi.org\/10.1038\/bjc.2015.233","journal-title":"British Journal of Cancer"},{"key":"10426_CR273","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12071971","volume":"12","author":"AJ Brooks","year":"2020","unstructured":"Brooks, A. J., & Putoczki, T. (2020). Jak-stat signalling pathway in cancer. Cancers (Basel), 12, 1\u20133. https:\/\/doi.org\/10.3390\/cancers12071971","journal-title":"Cancers (Basel)"},{"key":"10426_CR274","doi-asserted-by":"publisher","unstructured":"Herrera, S. C., Bach, E. A. (2019). JAK\/STAT signaling in stem cells and regeneration: From drosophila to vertebrates. Development, 146. https:\/\/doi.org\/10.1242\/dev.167643","DOI":"10.1242\/dev.167643"},{"key":"10426_CR275","doi-asserted-by":"publisher","first-page":"11755","DOI":"10.1074\/jbc.R800071200","volume":"284","author":"R Hill","year":"2009","unstructured":"Hill, R., & Wu, H. (2009). PTEN, stem cells, and cancer stem cells. Journal of Biological Chemistry, 284, 11755\u201311759. https:\/\/doi.org\/10.1074\/jbc.R800071200","journal-title":"Journal of Biological Chemistry"},{"key":"10426_CR276","doi-asserted-by":"publisher","unstructured":"Cheng, H. S., Yip, Y. S., Lim, E. K. Y., et al. (2021). PPARs and tumor microenvironment: The emerging roles of the metabolic master regulators in tumor stromal-epithelial crosstalk and carcinogenesis. Cancers (Basel), 13. https:\/\/doi.org\/10.3390\/cancers13092153","DOI":"10.3390\/cancers13092153"},{"key":"10426_CR277","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1158\/1078-0432.CCR-16-0775","volume":"22","author":"S Beyaz","year":"2016","unstructured":"Beyaz, S., & Yilmaz, \u00d6. H. (2016). Molecular pathways: Dietary regulation of stemness and tumor initiation by the PPAR-d pathway. Clinical Cancer Research, 22, 5636\u20135641. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0775","journal-title":"Clinical Cancer Research"},{"key":"10426_CR278","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-29967-6","volume":"8","author":"M Meyer-Hermann","year":"2018","unstructured":"Meyer-Hermann, M. (2018). Estimation of the cancer risk induced by therapies targeting stem cell replication and treatment recommendations. Science and Reports, 8, 1\u201316. https:\/\/doi.org\/10.1038\/s41598-018-29967-6","journal-title":"Science and Reports"},{"key":"10426_CR279","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.apsb.2020.09.016","volume":"11","author":"H Duan","year":"2021","unstructured":"Duan, H., Liu, Y., Gao, Z., & Huang, W. (2021). Recent advances in drug delivery systems for targeting cancer stem cells. Acta Pharm Sin B, 11, 55\u201370. https:\/\/doi.org\/10.1016\/j.apsb.2020.09.016","journal-title":"Acta Pharm Sin B"},{"key":"10426_CR280","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2017.00001","volume":"8","author":"W Qin","year":"2017","unstructured":"Qin, W., Huang, G., Chen, Z., & Zhang, Y. (2017). Nanomaterials in targeting cancer stem cells for cancer therapy. Frontiers in Pharmacology, 8, 1. https:\/\/doi.org\/10.3389\/fphar.2017.00001","journal-title":"Frontiers in Pharmacology"},{"key":"10426_CR281","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cas.12817","volume":"107","author":"GJ Yoshida","year":"2016","unstructured":"Yoshida, G. J., & Saya, H. (2016). Therapeutic strategies targeting cancer stem cells. Cancer Science, 107, 5\u201311. https:\/\/doi.org\/10.1111\/cas.12817","journal-title":"Cancer Science"},{"key":"10426_CR282","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s40684-021-00356-1","volume":"9","author":"JH Song","year":"2022","unstructured":"Song, J. H., Min, S. H., Kim, S. G., et al. (2022). Multi-functionalization Strategies Using Nanomaterials: A Review and Case Study in Sensing Applications. International Journal of Precision Engineering and Manufacturing-Green Technology, 9, 323\u2013347. https:\/\/doi.org\/10.1007\/s40684-021-00356-1","journal-title":"International Journal of Precision Engineering and Manufacturing-Green Technology"},{"key":"10426_CR283","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41524-017-0050-y","volume":"3","author":"S Angioletti-Uberti","year":"2017","unstructured":"Angioletti-Uberti, S. (2017). Theory, simulations and the design of functionalized nanoparticles for biomedical applications: A Soft Matter Perspective. npj Computational Materials, 3, 1\u201315. https:\/\/doi.org\/10.1038\/s41524-017-0050-y","journal-title":"npj Computational Materials"},{"key":"10426_CR284","unstructured":"Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04789486?term=nano&cond=cancer&draw=2&rank=10. Accessed 6 Jun 2022"},{"key":"10426_CR285","unstructured":"Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02079623?term=nano&cond=cancer&draw=2&rank=11. Accessed 6 Jun 2022"},{"key":"10426_CR286","unstructured":"Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00691054?term=nanoparticles&recrs=ade&cond=cancer&draw=2&rank=31. Accessed 6 Jun 2022"},{"key":"10426_CR287","unstructured":"Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00616967?term=nanoparticles&recrs=ade&cond=cancer&draw=2&rank=37. Accessed 6 Jun 2022"},{"key":"10426_CR288","unstructured":"Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT00662129?term=nanoparticles&recrs=ade&cond=cancer&draw=2&rank=3. Accessed 6 Jun 2022"},{"key":"10426_CR289","unstructured":"ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00110084?term=nanoparticles&recrs=ade&cond=cancer&draw=2&rank=8. Accessed 6 Jun 2022"},{"key":"10426_CR290","unstructured":"S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00856492?term=nanoparticles&recrs=ade&cond=cancer&draw=2&rank=13. Accessed 6 Jun 2022"},{"key":"10426_CR291","unstructured":"Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00553462?term=nanoparticles&recrs=ade&cond=cancer&draw=2&rank=19. Accessed 6 Jun 2022"},{"key":"10426_CR292","unstructured":"Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00729612?term=nanoparticles&recrs=ade&cond=cancer&draw=2&rank=21. Accessed 6 Jun 2022"},{"key":"10426_CR293","unstructured":"A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01812746?term=nanoparticles&recrs=ade&cond=cancer&draw=2&rank=26. Accessed 6 Jun 2022"},{"key":"10426_CR294","unstructured":"Phase II NCT (Neoadjuvant Chemotherapy) w\/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00675259?term=nanoparticles&recrs=ade&cond=cancer&draw=2&rank=29. Accessed 6 Jun 2022"},{"key":"10426_CR295","unstructured":"Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01620190?term=nanoparticles&recrs=ade&cond=cancer&draw=2&rank=30. Accessed 6 Jun 2022"},{"key":"10426_CR296","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.18632\/oncotarget.3348","volume":"6","author":"M Fiorillo","year":"2015","unstructured":"Fiorillo, M., Verre, A. F., Iliut, M., et al. (2015). Graphene oxide selectively targets cancer stem cells, across multiple tumor types: Implications for non-toxic cancer treatment, via \u201cdifferentiation-based nano-therapy.\u201d Oncotarget, 6, 3553\u20133562. https:\/\/doi.org\/10.18632\/oncotarget.3348","journal-title":"Oncotarget"},{"key":"10426_CR297","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3390\/ijms19030710","volume":"19","author":"YJ Choi","year":"2018","unstructured":"Choi, Y. J., Gurunathan, S., & Kim, J. H. (2018). Graphene oxide-silver nanocomposite enhances cytotoxic and apoptotic potential of salinomycin in human ovarian cancer stem cells (OvCSCs): A novel approach for cancer therapy. International Journal of Molecular Sciences, 19, 710. https:\/\/doi.org\/10.3390\/ijms19030710","journal-title":"International Journal of Molecular Sciences"},{"key":"10426_CR298","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.3390\/IJMS23105691","volume":"23","author":"N Knauer","year":"2022","unstructured":"Knauer, N., Arkhipova, V., Li, G., et al. (2022). In Vitro Validation of the Therapeutic Potential of Dendrimer-Based Nanoformulations against Tumor Stem Cells. International Journal of Molecular Sciences, 23, 5691. https:\/\/doi.org\/10.3390\/IJMS23105691","journal-title":"International Journal of Molecular Sciences"},{"key":"10426_CR299","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.1016\/j.biomaterials.2014.07.033","volume":"35","author":"HJ Yao","year":"2014","unstructured":"Yao, H. J., Zhang, Y. G., Sun, L., & Liu, Y. (2014). The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells. Biomaterials, 35, 9208\u20139223. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.07.033","journal-title":"Biomaterials"},{"key":"10426_CR300","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jconrel.2016.01.053","volume":"225","author":"A Al Faraj","year":"2016","unstructured":"Al Faraj, A., Shaik, A. S., Ratemi, E., & Halwani, R. (2016). Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model. Journal of Controlled Release, 225, 240\u2013251. https:\/\/doi.org\/10.1016\/j.jconrel.2016.01.053","journal-title":"Journal of Controlled Release"},{"key":"10426_CR301","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jconrel.2019.01.006","volume":"295","author":"Y Yi","year":"2019","unstructured":"Yi, Y., Kim, H. J., Zheng, M., et al. (2019). Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells. Journal of Controlled Release, 295, 268\u2013277. https:\/\/doi.org\/10.1016\/j.jconrel.2019.01.006","journal-title":"Journal of Controlled Release"},{"key":"10426_CR302","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1021\/acs.molpharmaceut.9b00132","volume":"16","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y., Zhao, W., Lim, Y. C., & Liu, T. (2019). Salinomycin-Loaded Gold Nanoparticles for Treating Cancer Stem Cells by Ferroptosis-Induced Cell Death. Molecular Pharmaceutics, 16, 2532\u20132539. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00132","journal-title":"Molecular Pharmaceutics"},{"key":"10426_CR303","doi-asserted-by":"publisher","first-page":"970","DOI":"10.7150\/thno.11632","volume":"5","author":"S Liang","year":"2015","unstructured":"Liang, S., Li, C., Zhang, C., et al. (2015). CD44v6 monoclonal antibody-conjugated gold nanostars for targeted photoacoustic imaging and plasmonic photothermal therapy of gastric cancer stem-like cells. Theranostics, 5, 970\u2013984. https:\/\/doi.org\/10.7150\/thno.11632","journal-title":"Theranostics"},{"key":"10426_CR304","doi-asserted-by":"publisher","unstructured":"Poonaki, E., Nickel, A. C., Ardestani, M. S., et al. (2022). CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells. International Journal of Molecular Sciences, 23. https:\/\/doi.org\/10.3390\/IJMS23105479\/S1","DOI":"10.3390\/IJMS23105479\/S1"},{"key":"10426_CR305","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.2147\/IJN.S197265","volume":"14","author":"E Locatelli","year":"2019","unstructured":"Locatelli, E., Li, Y., Monaco, I., et al. (2019). A novel theranostic gold nanorods- and adriamycin-loaded micelle for EpCA M targeting, laser ablation, and photoacoustic imaging of cancer stem cells in hepatocellular carcinoma. International Journal of Nanomedicine, 14, 1877\u20131892. https:\/\/doi.org\/10.2147\/IJN.S197265","journal-title":"International Journal of Nanomedicine"},{"key":"10426_CR306","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1021\/acsnano.5b07172","volume":"10","author":"Y Liu","year":"2016","unstructured":"Liu, Y., Yang, M., Zhang, J., et al. (2016). Human Induced Pluripotent Stem Cells for Tumor Targeted Delivery of Gold Nanorods and Enhanced Photothermal Therapy. ACS Nano, 10, 2375\u20132385. https:\/\/doi.org\/10.1021\/acsnano.5b07172","journal-title":"ACS Nano"},{"key":"10426_CR307","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/10717544.2019.1580799","volume":"26","author":"J Zhou","year":"2019","unstructured":"Zhou, J., Sun, M., Jin, S., et al. (2019). Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells. Drug Delivery, 26, 281\u2013289. https:\/\/doi.org\/10.1080\/10717544.2019.1580799","journal-title":"Drug Delivery"},{"key":"10426_CR308","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115112","volume":"401","author":"P Arthur","year":"2020","unstructured":"Arthur, P., Patel, N., Surapaneni, S. K., et al. (2020). Targeting lung cancer stem cells using combination of Tel and Docetaxel liposomes in 3D cultures and tumor xenografts. Toxicology and Applied Pharmacology, 401, 115112. https:\/\/doi.org\/10.1016\/j.taap.2020.115112","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10426_CR309","doi-asserted-by":"publisher","unstructured":"Wang, Z., Sun, M., Li, W., et al. (2020). A Novel CD133- and EpCAM-Targeted Liposome With Redox-Responsive Properties Capable of Synergistically Eliminating Liver Cancer Stem Cells. Frontiers in Chemistry, 8. https:\/\/doi.org\/10.3389\/FCHEM.2020.00649","DOI":"10.3389\/FCHEM.2020.00649"},{"key":"10426_CR310","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.biomaterials.2013.10.049","volume":"35","author":"XY Ke","year":"2014","unstructured":"Ke, X. Y., Lin Ng, V. W., Gao, S. J., et al. (2014). Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials, 35, 1096\u20131108. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.10.049","journal-title":"Biomaterials"},{"key":"10426_CR311","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/CAD.0000000000000541","volume":"28","author":"L Li","year":"2017","unstructured":"Li, L., Cui, D., Ye, L., et al. (2017). Codelivery of salinomycin and docetaxel using poly(d, l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells. Anti-Cancer Drugs, 28, 989\u20131001. https:\/\/doi.org\/10.1097\/CAD.0000000000000541","journal-title":"Anti-Cancer Drugs"},{"key":"10426_CR312","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.01.068","volume":"51","author":"CF Xu","year":"2015","unstructured":"Xu, C. F., Liu, Y., Shen, S., et al. (2015). Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy. Biomaterials, 51, 1\u201311. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.01.068","journal-title":"Biomaterials"},{"key":"10426_CR313","doi-asserted-by":"publisher","DOI":"10.1016\/J.MSEC.2021.112024","volume":"124","author":"E Espinosa-Cano","year":"2021","unstructured":"Espinosa-Cano, E., Huerta-Madro\u00f1al, M., C\u00e1mara-S\u00e1nchez, P., et al. (2021). Hyaluronic acid (HA)-coated naproxen-nanoparticles selectively target breast cancer stem cells through COX-independent pathways. Materials Science and Engineering C, 124, 112024. https:\/\/doi.org\/10.1016\/J.MSEC.2021.112024","journal-title":"Materials Science and Engineering C"},{"key":"10426_CR314","doi-asserted-by":"publisher","unstructured":"Moro, M., Fortunato, O., Bertolini, G., et al. (2022). MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85\/AKT Pathway. Pharmaceuticals, 15. https:\/\/doi.org\/10.3390\/PH15030297\/S1","DOI":"10.3390\/PH15030297\/S1"},{"key":"10426_CR315","doi-asserted-by":"publisher","first-page":"26","DOI":"10.12122\/J.ISSN.1673-4254.2022.01.03","volume":"42","author":"L Pang","year":"2022","unstructured":"Pang, L., Huang, X., Zhu, L., et al. (2022). Targeted killing of CD133 + lung cancer stem cells using paclitaxel-loaded PLGA-PEG nanoparticles with CD133 aptamers. Nan Fang Yi Ke Da Xue Xue Bao, 42, 26\u201335. https:\/\/doi.org\/10.12122\/J.ISSN.1673-4254.2022.01.03","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10426_CR316","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3389\/FCHEM.2020.601649\/BIBTEX","volume":"8","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y., Wang, K., Zheng, Y., et al. (2021). Co-delivery of Salinomycin and Curcumin for Cancer Stem Cell Treatment by Inhibition of Cell Proliferation, Cell Cycle Arrest, and Epithelial-Mesenchymal Transition. Frontiers in Chemistry, 8, 1149. https:\/\/doi.org\/10.3389\/FCHEM.2020.601649\/BIBTEX","journal-title":"Frontiers in Chemistry"},{"key":"10426_CR317","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0680-z","volume":"37","author":"J Jiang","year":"2018","unstructured":"Jiang, J., Li, H., Qaed, E., et al. (2018). Salinomycin, as an autophagy modulator - A new avenue to anticancer: A review. Journal of Experimental & Clinical Cancer Research, 37, 1\u201313. https:\/\/doi.org\/10.1186\/s13046-018-0680-z","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10426_CR318","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/pharmaceutics13081120","volume":"13","author":"LR Tefas","year":"2021","unstructured":"Tefas, L. R., Barb\u0103lat\u0103, C., Tefas, C., & Tomu\u021b\u0103, I. (2021). Salinomycin-based drug delivery systems: Overcoming the hurdles in cancer therapy. Pharmaceutics, 13, 1120. https:\/\/doi.org\/10.3390\/pharmaceutics13081120","journal-title":"Pharmaceutics"},{"key":"10426_CR319","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/IJMS18051088","volume":"18","author":"KY Kim","year":"2017","unstructured":"Kim, K. Y., Il, P. K., Kim, S. H., et al. (2017). Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K\/AKT\/mTOR and ERK\/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells. International Journal of Molecular Sciences, 18, 1088. https:\/\/doi.org\/10.3390\/IJMS18051088","journal-title":"International Journal of Molecular Sciences"},{"key":"10426_CR320","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.3389\/FONC.2021.654428\/BIBTEX","volume":"11","author":"H Wang","year":"2021","unstructured":"Wang, H., Zhang, H., Zhu, Y., et al. (2021). Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications. Frontiers in Oncology, 11, 2748. https:\/\/doi.org\/10.3389\/FONC.2021.654428\/BIBTEX","journal-title":"Frontiers in Oncology"},{"key":"10426_CR321","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPHA.2021.111815","volume":"141","author":"A Urbaniak","year":"2021","unstructured":"Urbaniak, A., Reed, M. R., Fil, D., et al. (2021). Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models. Biomedicine & Pharmacotherapy, 141, 111815. https:\/\/doi.org\/10.1016\/J.BIOPHA.2021.111815","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10426_CR322","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1039\/D1OB02292J","volume":"20","author":"B Li","year":"2022","unstructured":"Li, B., Wu, J., Tang, L., et al. (2022). Synthesis and anti-tumor activity evaluation of salinomycin C20- O -alkyl\/benzyl oxime derivatives. Organic & Biomolecular Chemistry, 20, 870\u2013876. https:\/\/doi.org\/10.1039\/D1OB02292J","journal-title":"Organic & Biomolecular Chemistry"},{"key":"10426_CR323","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1021\/ACSORGINORGAU.1C00046","volume":"2022","author":"D Czerwonka","year":"2022","unstructured":"Czerwonka, D., M\u00fc, S., Ca\u00f1, T., et al. (2022). Expeditive Synthesis of Potent C20-epi-Amino Derivatives of Salinomycin against Cancer Stem-Like Cells. ACS Organic & Inorganic Au, 2022, 214\u2013221. https:\/\/doi.org\/10.1021\/ACSORGINORGAU.1C00046","journal-title":"ACS Organic & Inorganic Au"},{"key":"10426_CR324","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S10876-022-02249-Y","volume":"2022","author":"R Li","year":"2022","unstructured":"Li, R., Guo, N., Fu, L., & Miao, Y. (2022). A Feasible Strategy of Fabricating Redox-Responsive Polymeric Salinomycin Small Molecule Prodrug Delivery for Liver Cancer Therapy. Journal of Cluster Science, 2022, 1\u201311. https:\/\/doi.org\/10.1007\/S10876-022-02249-Y","journal-title":"Journal of Cluster Science"},{"key":"10426_CR325","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fbioe.2019.00415","volume":"7","author":"OS Thomas","year":"2019","unstructured":"Thomas, O. S., & Weber, W. (2019). Overcoming Physiological Barriers to Nanoparticle Delivery\u2014Are We There Yet? Front Bioeng Biotechnol, 7, 415. https:\/\/doi.org\/10.3389\/fbioe.2019.00415","journal-title":"Front Bioeng Biotechnol"},{"key":"10426_CR326","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/J.COLSURFB.2018.08.063","volume":"172","author":"DS Liang","year":"2018","unstructured":"Liang, D. S., Liu, J., Peng, T. X., et al. (2018). Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy. Colloids Surfaces B Biointerfaces, 172, 506\u2013516. https:\/\/doi.org\/10.1016\/J.COLSURFB.2018.08.063","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10426_CR327","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.2147\/IJN.S236928","volume":"15","author":"J Wang","year":"2020","unstructured":"Wang, J., Zhuo, J., Tao, Y., et al. (2020). <p>Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma<\/p>. International Journal of Nanomedicine, 15, 6839\u20136854. https:\/\/doi.org\/10.2147\/IJN.S236928","journal-title":"International Journal of Nanomedicine"},{"key":"10426_CR328","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/APS.2018.17","volume":"39","author":"W Sun","year":"2018","unstructured":"Sun, W., Luo, J. D., Jiang, H., & Duan, D. D. (2018). Tumor exosomes: A double-edged sword in cancer therapy. Acta Pharmacologica Sinica, 39, 534. https:\/\/doi.org\/10.1038\/APS.2018.17","journal-title":"Acta Pharmacologica Sinica"},{"key":"10426_CR329","doi-asserted-by":"publisher","unstructured":"Aqil, F., Gupta, R. C. (2022). Exosomes in Cancer Therapy. Cancers (Basel), 14. https:\/\/doi.org\/10.3390\/CANCERS14030500","DOI":"10.3390\/CANCERS14030500"},{"key":"10426_CR330","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/S00467-017-3816-Z","volume":"34","author":"AL St\u00e5hl","year":"2019","unstructured":"St\u00e5hl, A. L., Johansson, K., Mossberg, M., et al. (2019). Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases. Pediatric Nephrology (Berlin, Germany), 34, 11\u201330. https:\/\/doi.org\/10.1007\/S00467-017-3816-Z","journal-title":"Pediatric Nephrology (Berlin, Germany)"},{"key":"10426_CR331","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.nantod.2015.11.009","volume":"10","author":"B Lee Chung","year":"2015","unstructured":"Lee Chung, B., Toth, M. J., Kamaly, N., et al. (2015). Nanomedicines for endothelial disorders. Nano Today, 10, 759\u2013776. https:\/\/doi.org\/10.1016\/j.nantod.2015.11.009","journal-title":"Nano Today"},{"key":"10426_CR332","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S11671-021-03588-X\/FIGURES\/4","volume":"16","author":"Y Du","year":"2021","unstructured":"Du, Y., Wang, S., Zhang, M., et al. (2021). Cells-Based Drug Delivery for Cancer Applications. Nanoscale Research Letters, 16, 1\u201310. https:\/\/doi.org\/10.1186\/S11671-021-03588-X\/FIGURES\/4","journal-title":"Nanoscale Research Letters"},{"key":"10426_CR333","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1158\/1078-0432.CCR-16-2358","volume":"23","author":"JM Garcia-Heredia","year":"2017","unstructured":"Garcia-Heredia, J. M., Lucena-Cacace, A., Verdugo-Sivianes, E. M., et al. (2017). The cargo protein MAP17 (PDZK1IP1) regulates the cancer stem cell pool activating the Notch pathway by abducting NUMB. Clinical Cancer Research, 23, 3871\u20133883. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2358","journal-title":"Clinical Cancer Research"},{"key":"10426_CR334","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.drudis.2018.01.030","volume":"23","author":"S Pinho","year":"2018","unstructured":"Pinho, S., Macedo, M. H., Rebelo, C., et al. (2018). Stem cells as vehicles and targets of nanoparticles. Drug Discovery Today, 23, 1071\u20131078. https:\/\/doi.org\/10.1016\/j.drudis.2018.01.030","journal-title":"Drug Discovery Today"},{"key":"10426_CR335","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13046-020-01548-4\/FIGURES\/5","volume":"39","author":"S Lenna","year":"2020","unstructured":"Lenna, S., Bellotti, C., Duchi, S., et al. (2020). Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model. Journal of Experimental & Clinical Cancer Research, 39, 1\u201315. https:\/\/doi.org\/10.1186\/S13046-020-01548-4\/FIGURES\/5","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10426_CR336","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s12015-021-10192-0","volume":"17","author":"AR Mercer-Smith","year":"2021","unstructured":"Mercer-Smith, A. R., Findlay, I. A., Bomba, H. N., & Hingtgen, S. D. (2021). Intravenously Infused Stem Cells for Cancer Treatment. Stem Cell Rev Reports, 17, 2025\u20132041. https:\/\/doi.org\/10.1007\/s12015-021-10192-0","journal-title":"Stem Cell Rev Reports"},{"key":"10426_CR337","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3389\/FCELL.2021.686453\/BIBTEX","volume":"9","author":"A Hassanzadeh","year":"2021","unstructured":"Hassanzadeh, A., Altajer, A. H., Rahman, H. S., et al. (2021). Mesenchymal Stem\/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy. Front Cell Dev Biol, 9, 1758. https:\/\/doi.org\/10.3389\/FCELL.2021.686453\/BIBTEX","journal-title":"Front Cell Dev Biol"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-022-10426-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-022-10426-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-022-10426-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T17:47:09Z","timestamp":1663696029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-022-10426-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":337,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10426"],"URL":"https:\/\/doi.org\/10.1007\/s12015-022-10426-9","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"assertion":[{"value":"10 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have contributed to the article and approved the submitted version.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare they have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest\/Competing Interests"}}]}}